Find a Physician by Specialty

About the Lifespan Cancer Institute team

Lifespan Cancer Institute physicians work collaboratively in disease-specific teams to provide leading-edge, patient-centered cancer care and access to the latest, most appropriate clinical trials for each patient.

This care is offered at all our locations: Rhode Island, The Miriam, and Newport hospitals and the Lifespan Ambulatory Care Center in East Greenwich. We bring the  expert care to the places where our patients live and work.

Our physicians and scientists have pioneered groundbreaking treatments for cancers through their research and leadership in national and international cooperative groups of cancer researchers. LCI physicians’ expertise positions our cancer center among a select group of sites in the world participating in the most innovative clinical trials that are driving the next generation of immunotherapy and genomic-based treatments for cancer.

Partnership with the Brown University Oncology Group is also instrumental to our ultimate mission to improve the lives of patients with cancer through better treatments and care.

Select one of the specialties below to learn about the physicians whose outstanding care will achieve the best outcomes.

Find a Cancer Specialist

Quickly find a physician by clicking on one of these specialties:

Brain and Spine Center

Neurosurgery

Neurosurgeon-in-Chief, Rhode Island Hospital and The Miriam Hospital

Ziya L. Gokaslan, MD, FAANS, FACS, serves as the chief of neurosurgery at Rhode Island and The Miriam hospitals, director of the Comprehensive Spine Center at Rhode Island Hospital, and clinical director of the Norman Prince Neurosciences Institute. In addition, Dr. Gokaslan is the Gus Stoll Professor of Neurosurgery, chair of the department of neurosurgery, and director of the Complex Spinal Surgery Fellowship at The Warren Alpert Medical School of Brown University.

Gokaslan earned his medical degree from the University of Istanbul in Turkey. He completed an internship in general surgery, a fellowship in neurotraumatology, a residency in neurosurgery at Baylor College of Medicine in Houston, and a fellowship in clinical spinal surgery at New York University Medical Center. He is a recipient of numerous prestigious awards and an active member of several professional societies.   

Gokaslan comes to Lifespan from Johns Hopkins in Baltimore, where he was vice chairman of the department of neurosurgery, director of the neurosurgical spine program, and director of the neurosurgical spine metastasis center, as well as professor of neurology, oncology, and orthopedic surgery at Johns Hopkins University School of Medicine. His practice focuses on complex spinal reconstruction and radical surgical treatment of both primary and metastatic spinal tumors, sacral neoplasms, and spinal cord tumors.

Director, Brain Tumor and Stereotactic Radiosurgery Program

Steven A. Toms, MD, is a board-certified neurosurgeon and vice chair for the department of neurosurgery at Rhode Island Hospital. He is a professor of neurosurgery, medicine and health services, policy and practice at The Warren Alpert Medical School of Brown University. He has been the principal investigator of both basic and clinical research studies, including studies on the development of therapeutic approaches for primary brain tumors and cancer metastasis to the brain.

He is the director of the brain tumor program for Lifespan Health Systems and is jointly responsible for the Gamma Knife and Cyberknife units with radiation oncology.  Dr. Toms has been published in more than 80 medical journals and multiple book chapters.  He has edited one book and served as editor and reviewer for a number of publications. He is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons and the Society for Neuro-Oncology.

Director, Spinal Surgery Division, Surgical Director, Comprehensive Spine Center

Adetokunbo Oyelese, MD, PhD, FAANS is the director of the spinal surgery division and the surgical director for the Comprehensive Spine Center at Rhode Island Hospital. He is board certified by The American Board of Neurological Surgery and specializes in complex spinal disorders. He is an associate professor in the Department of Neurosurgery and the assistant program director of the neurosurgery residency program at The Warren Alpert Medical School of Brown University. His research interests lie in understanding repair and plasticity within the spine and spinal cord.
 
His practice includes patients with trauma to the spine. He also has a special interest in the management and treatment of complex degenerative diseases of the spine, including spinal stenosis, degenerative disc disease, and spinal deformity, as well as treatment of tumors arising from the spine and spinal cord. He offers patients cutting-edge surgical techniques such as minimally invasive spine surgery, artificial disc replacement surgery and Cyberknife stereotactic radiosurgery for tumors involving the spine and spinal cord.
 
Dr. Oyelese earned his medical and doctoral degrees from Yale University School of Medicine, where he was elected to the Alpha Omega Alpha (AOA) honor medical society. He completed his residency in neurosurgery at Stanford University and fellowship training at the Cedars-Sinai Institute for Spinal Disorders.

Director, Stereotactic Radiosurgery, Program Director, Peripheral Nerve Surgery Division

Deus Cielo, MD received his medical degree from the Brown-Dartmouth Medical Program of Dartmouth Medical School and Brown Medical School. He remained at Brown where he completed his internship in general surgery, as well as his residency training in neurological surgery.

After completion of his training, he joined the department of neurosurgery at The Warren Alpert Medical School of Brown University where he is an assistant professor.

Dr. Cielo is board certified by the American Board of Neurological Surgery and specializes in adult general neurosurgery. He is also a member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons.

Director, Cerebrovascular and Skull-Base Surgery

Curtis Doberstein, MD is the director of cerebrovascular and skull-base surgery at Rhode Island Hospital and executive vice-chair of clinical operations. In addition, Dr. Doberstein is director of the Neurosurgery Residency Program and professor of neurosurgery at The Warren Alpert Medical School of Brown University. Dr. Doberstein received his medical degree in 1988 from McGill University in Montreal and completed his residency in neurosurgery and fellowship at the University of California at Los Angeles.

Dr. Doberstein has been board-certified by the American Board of Neurosurgery since 2000. He served as interim chairman of neurosurgery at the Warren Alpert Medical School of Brown University from 2007 to 2010. In 1995, Dr. Doberstein joined the Neurosurgery Foundation and the Warren Alpert Medical School of Brown University. He is an associate professor (clinical) in the department of neurosurgery at Brown and serves as the Brown University neurosurgery residency program director. He directs the section of vascular neurosurgery at Rhode Island Hospital. He is an active member of the American Association of Neurological Surgeons and Congress of Neurologic Surgeons and serves as a MOC/CME committee member for the American Association of Neurological Surgeons.

Dr. Doberstein specializes in surgery on the blood vessels of the brain, neck and spinal column. He sees many patients with circulatory problems such as aneurysms, arteriovenous malformations and carotid artery disease. He also treats patients with nervous system tumors, including those of the brain and the skull base. Patients with degenerative spine disorders comprise another large part of his practice.

Research Interests

Dr. Doberstein, MD has conducted research on apoptosis after stroke and cerebral metabolic alterations following closed head injuries.

At present, he is investigating clinical outcomes following the removal of plaque from a carotid artery. He has performed more than 500 of these surgeries. Specifically, he is exploring the feasibility of same-day discharge after carotid endarterectomry.

Professional Papers

  • Group B Beta-Hemolytic Osteomyelitis of the Heel: A Case Report. Doberstein C, MacEwen GD, Lee MS Clin Orthop 213:225-228 1988
  • Intraoperative Angiography in Cerebrovascular Surgery. Martin NA, Doberstein C, Bentson J, Vinuela F, Dion J, Becker DP Clin Neurosurg 37:312-331 1990
  • Cystic Neoplasms of the Pancreas. Doberstein C, Kirchner R, Gordon L, Morgenstern L, Shapiro S Mt. Sinai J.Med 57:102-106 1990
  • Post-traumatic Cerebral Arterial Spasm: Transcranial Doppler Ultrasound, Cerebral Blood Flow, and Angiographic Findings. Martin NA, Doberstein C, Caron M, Zane C, Thomas K, Becker DP J. Neurosurg, 77:575-583 1992
  • Clinical Considerations in the Doberstein C, Hovda DA, Becker DB Ann Emerg Med, 22:993-997 1993
  • Metabolic Alterations Accompany Ionic Disturbances and Cellular Doberstein C, Fineman I, Hovda DA, Martin NA, Keenly L, Becker DP Acta Neurochir (Suppl)60:41-44 1994
  • Cerebral Blood Flow Measurement in Martin NA, Doberstein C Neurosurg Clin N. Amer, 5(4):607-618 1994
  • Post-traumatic Cerebral Arterial Spasm Martin NA, Doberstein C, Alexander MJ, Khanna R, Benzalcazar H, Alsina G, Zane C, McBride D, Kelly D, Houda D, Becker DB, McArthur D, Zavcha K J Neurotrauma, 12(5): 897-901 1995
  • Temporally Associated Rupture of Guglielmo MA, Doberstein C A Case Report. J.1998
  • The temporal Profile and Morphologic Features of Neuronal Death in Human Stroke Resemble Those Observed in Experimental Forebrain Ischemia: The Potential Role of Apoptosis. Guglielmo MA, Chan PT, Cortez S, Stopa E, McMillan P, Johanson CE, Epstein M, Doberstein CE Neurol Res 20:289-296 1998
  • Therapeutic Embolization Arteriovenous Malformations: The Case For and Against Martin N, Khanna R, Doberstein C, Benston J. Clinical Neurosurgery, Vol. 46, 295-318 1998
  • Assessment of the Value of MR Imaging for Examining Patients with Angiographically Negative Subarachnoid Hemorrhage Rogg JM, Smeaton S, Doberstein C, Goldstein JH, Tung GA, Haas RA AJR 172:201-206 1999
  • Intracanalicular Aneurysm of the Anterior Inferior Cerebellar Artery Revealed by Multi- Detector CT Angiography. Jayaraman MV, Mayo-Smith WW, Doberstein CE AJR Am J Neuroradiol 24(7): 1338-40 2003
  • Recovery of choroid plexus function in aged rats subjected to transient forebrain ischemia Johanson C, Palm D, Doberstein C, Stopa E Neurosci. Lett., in press.
  • Sustained CA1 Neuronal Survival by FGF-Z Following Forebrain Ischemia In The Rat: A Possible Role For The Choroid Plexus-CSF System. Hayamizv T, Chan PT, Doberstein C, Sunwoo L, Guglielmo MA, Hayamizv T, Chan PT, Doberstein C, Sunwoo L, Guglielmo MA, Hayamizv T, Chan PT, Doberstein C, Sunwoo L, Guglielmo MA, Johanson, CE. Neurological Research
  • Spontaneous thrombosis of a cerebral arteriovenous malformation: A case report. Sungarian A, Doberstein C, Haas R Scandinavian J. Nsurg.
Director, Center for Minimally Invasive Endoscopic Spinal Surgery

Albert Telfeian, MD, PhD, leads the endoscopic spine surgery program. A world-renown leader in endoscopic spinal surgery with national and international patient referral base, has been also appointed as the Director of newly established Center for Minimally Invasive Endoscopic Spinal Surgery at Rhode Island Hospital/Brown University. He is board certified by The American Board of Neurological Surgery and is an Associate Professor of Neurosurgery at The Warren Alpert School of Medicine at Brown University. Previously he was an assistant professor of neurosurgery at Children’s Hospital of Philadelphia and associate professor of neurosurgery at Texas Tech University Health Sciences Center.

Dr. Telfeian also serves as Vice Chair for Quality Improvement to improve the quality of care for patients.

He is a graduate of the MD/PhD program at The Warren Alpert Medical School of Brown University and completed a postdoctoral fellowship at Yale University and his neurosurgical residency at the Hospital of the University of Pennsylvania. He also completed fellowship training in spine and functional epilepsy surgery at Switzerland’s Centre Hospitalier Universitaire Vaudois and a pediatric neurosurgery fellowship at Children’s Hospital of Philadelphia.

Dr. Telfeian has published extensively in the areas of epilepsy, functional and spine surgery and is currently involved in the research and development of ultra-minimally invasive endoscopic techniques. He was the recipient of the American Association of Neurologic Surgeons Stereotactic and Functional Neurosurgery Research Award, the American Epilepsy Society Young Investigator Award, and the J. Kiffin Penry Pediatric Epilepsy Award, and was named one of the nation’s 15 leaders in neurosurgery in the October 2011 edition of Newsweek.

Professional Papers

  • Smith SE, Kirkham FJ, , Deveber G, Millman G, Dirks PB, Wirrell E, Telfeian AE, Sykes K, Barow K, Ichord R.Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in children. Dev Med Child Neurol 2010 Aug 30.
  • Simon SL, Auerbach JD, Garg S, Sutton L, Telfeian AE, Dormans JP. Efficacy of spinal instrumentation and fusion in the prevention of postlaminectomy spinal deformity in children with intramedullary spinal cord tumors. J Pediatr Orthop 2008 vol 28, No. 2.
  • Porter BE, Zhang G, Celix J, Hsu FC, Raol YH, Telfeian AE, Gallagher PR, Coulter DA, Brooks-Kayal AR.Heterogeneous GABAA receptor subunit expression in pediatric epilepsy patients. Neurobiol Dis 2005 Apr;18(3):484-91.
  • Sestokas AK, Telfeian AE, Duhaime AC, Sutton L, Sestokas LO, Schwartz DM.Intraoperative motor cortex mapping in children with intractable seizures using motor evoked potential (MEP) threshold gradients. J Clin Neurophys 2005 Oct;22(5).
  • Telfeian AE, Judkins A, Younkin D, Pollock AN, Crino P. Subependymal giant cell astrocytoma with cranial and spinal metastases in a patient with tuberous sclerosis. Journal of Neurosurgery (Pediatrics 5) 2004;100:498-501.
  • Telfeian AE, Landa J, Drummond D. Congenital formation of an intraspinal osseous vertebral ring causing spinal cord compression. Spine 2004 Jan;29(1):E1-3.
Director, Center for CSF Disorders of the Brain and Spine, Director, Pediatric Neurosurgery Division

Petra Klinge, MD is an internationally renowned general neurosurgeon specializing in the surgical treatment of patients with brain tumors, hydrocephalus and Alzheimer’s disease, pediatric diseases and treatment of congenital diseases like Chiari and spinal malformations.

Dr. Klinge is a professor of neurosurgery at The Warren Alpert School of Medicine at Brown University. Prior to this, she was professor of neurosurgery at the Medical School Hannover, Germany. She received her medical degree at the University of Kiel in 1993 and completed her neurosurgical residency at Hannover Medical School in Germany in 2002. She was senior associate professor of neurosurgery at the International Neuroscience Institute in Hannover, Germany, where she had the opportunity to be educated by Professor M. Samii, a founder of modern skull base surgery.

Dr. Klinge is an active member of the American Association of Neurosurgeons and the Congress of Neurological Surgeons. She is editor in chief of the Elsevier journal Interdisciplinary Neurosurgery: Advanced Techniques and Case Management (INAT) and associate editor of Clinical Neurology and Neurosurgery (CNN). She also serves as reviewer for international scientific journals including NeurosurgeryJournal of NeurosurgeryJournal of NeurologyNeurosurgery & Psychiatry and others. She is past president of the International Society for Hydrocephalus and CSF disorders.

Dr. Klinge’s scientific interests comprise the development of advanced techniques for diagnosing and treatment of dementia, experimental work to advance the understanding of normal aging and dementia and to develop novel biotechnical treatment approaches including stem cell therapy. Her scientific publications are listed by the US National Library of Medicine.

Professional Papers

  • Multiplicity of Cerebrospinal Fluid Functions: New Challenges in Health and Disease Conrad E. Johanson; John A. Duncan; Petra M. Klinge; Edward G. Stopa and Gerald PD. Silverberg. Cerebrospinal Fluid Research 2008
  • Modified calcium accumulation after controlled cortical impact under cyclosporin A treatment: a (45)Ca autoradiographic study. Mirzayan MJ; Klinge PM; Ude S; Hotop A; Samii M; Brinker T; Korkmaz Z; Meyer GJ; Knapp WH; Samii A. Neurol Res. 2008
  • Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting-A retrospective analysis of [(15)O]H(2)O PET-CBF studies in 65 patients. Klinge PM; Brooks DJ; Samii A; Weckesser E; van den Hoff J; Fricke H; Brinker T; Knapp WH; Berding G. Clinical Neurol Neurosurg 2008
  • A positron emission tomography study of cerebrovascular reserve before and after shunt surgery in patients with idiopathic chronic hydrocephalus. Klinge PM; Berding G; Brinker T; Knapp WH; Samii M. J Neurosurg. 1999 Oct; 91(4): 605-9.
  • Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients. Klinge P; Marmarou A; Bergsneider M; Relkin N; Black PM. Neurosurgery. 2005 Sep; 57 (3 Suppl):S40-52
  • Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting-A retrospective analysis of [(15)O]H(2)O PET-CBF studies in 65 patients. Klinge PM; Brooks DJ; Samii A; Weckesser E; van den Hoff J; Fricke H; Brinker T; Knapp WH; Berding G. Clinical Neurol Neurosurg 2008
  • Amyloid and Tau accumulate in the brains of aged hydrocephalic rats. Gerald D. Silverberg, Miles C. Miller, Jason T. Machan, Conrad E. Johanson, Ilias N. Caralopoulos, Crissey L. Pascale, Anna Heile, Petra M. Klinge. BRAIN RESEARCH 1317 (2010) 286 – 296
Director, Spinal Surgical Outcomes Laboratory

Jared Fridley, MD, is a neurosurgeon subspecializing in complex spinal surgery. He is an assistant professor and director of the Spine Surgery Outcomes Research Laboratory at The Warren Alpert Medical School of Brown University.

Dr. Fridley’s work has been published in many peer-reviewed articles and book chapters. He is a member of the Congress of Neurological Surgeons and the American Academy of Neurologic Surgeons. His clinical interests include degenerative spinal disease, spinal trauma, tumors and deformities, and peripheral nerve surgery. His research interests include spinal surgery outcomes and spinal cord injury. 

Director, Functional Neurosurgery & Epilepsy Program; Co-Director, Deep Brain Stimulation; Laboratory Director, Cognitive Neurophysiology & Neuromodulation

Wael Asaad, MD, PhD received his undergraduate degree from Amherst College in 1993, then earned a PhD in systems neuroscience from Massachusetts Institute of Technology in 2001, and his MD from Yale University in 2003. Asaad completed a general surgery internship and neurosurgical residency at the Massachusetts General Hospital. During his residency, he undertook additional training in functional neurosurgery. In 2011, he joined the department of neurosurgery at The Warren Alpert Medical School of Brown University.

Asaad's clinical interests include functional neurosurgery for movement disorders and psychiatric disease, traumatic brain injury, and general neurosurgery of the brain and spine.

His basic science interests focus on the ways in which neuronal circuits in the frontal cortex and basal ganglia underlie visual-motor learning, memory and decision-making, and how a better understanding of these might lead to strategies to alleviate the cognitive aspects of psychiatric and neurological diseases, including traumatic brain injury and stroke.

Learn more about Deep Brain Stimulation.

Learn more about the Department of Neurosurgery.

Learn more about the Movement Disorders Program.

See Dr. Asaad's publication list at Google Scholar.

Pediatric Neurosurgery

Pediatric Neurosurgeon

Konstantina Svokos, DO, is a neurosurgeon who specializes in pediatric neurosurgery. She has done both clinical and molecular research throughout her training and her work has been published in several peer-reviewed journals and book chapters.

Dr. Svokos is fluent in English, Greek and Spanish. She is a member of the Society for Neuro Oncology, the American College of Osteopathic Surgeons, the Congress of Neurological Surgeons and the American Association of Neurological Surgeons.

Neuro-Oncology

Neuro-Oncology Medical Lead, Lifespan Cancer Institute

Heinrich Elinzano, MD is an adult neurologist, with subspecialty training in neuro-oncology and spinal cord injury medicine, and is also an assistant professor of neurology at The Warren Alpert Medical School of Brown University. He is experienced in the management of tumors of the central nervous system and has a particular interest in conducting clinical trials for the treatment of primary brain tumors and the neurological complications of systemic cancer.

Elinzano completed his neurology residency at St. Vincent Hospital and Medical Center of New York, his spinal cord injury medicine fellowship training at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, Missouri, and his neuro-oncology fellowship training at The Johns Hopkins University School of Medicine in Baltimore and The Neuro-Oncology Branch of the U.S. National Institutes of Health's National Cancer Institute and National Institute of Neurologic Diseases and Stroke. Prior to his current position at Rhode Island Hospital, he was an adult neuro-oncologist at the Cleveland Clinic Brain Tumor and Neuro-Oncology Center.

Chief, Hematology Oncology

Howard P. Safran, MD is the chief of hematology/oncology at the Lifespan Cancer Institute at Rhode Island, The Miriam and Newport hospitals, and the medical director for the Brown University Oncology Group. Safran is a professor of medicine at The Warren Alpert Medical School of Brown University and a nationally recognized leader in the development of new treatments for upper GI cancers. He is a member of the U.S. National Cancer Institute's pancreatic and gastrointestinal cancer task forces.

Medical Oncology

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Pediatric Oncology

Pediatric Hematology/Oncology Specialist

Bradley DeNardo, MD, is a board-certified pediatrician who specializes in pediatric hematology and oncology at Hasbro Children’s Hospital. He is an assistant professor of pediatrics at The Warren Alpert Medical School of Brown University. After attending The Warren Alpert Medical School, Dr. DeNardo continued dedicating his time to the medical students there by instructing them in pediatrics for the following nine years. In addition, Dr. DeNardo is a consulting physician at Women and Infants Hospital.

Dr. DeNardo’s work has been published in several peer-reviewed journals and books, and he has also presented his research at the local, regional and international levels. He is a member of a number of professional societies, including Children’s Oncology Group and the American Society of Pediatric Hematology/Oncology.

Chief of Pediatric Hematology/Oncology

Rishi R. Lulla, MD, MS, is the chief of pediatric hematology/oncology at Hasbro Children’s Hospital and an international expert in the care of children and young adults with brain and spinal cord tumors. After completing his residency and fellowship at Northwestern University in Chicago, Dr. Lulla spent several years as an attending physician on the pediatric neuro-oncology team at Northwestern. He has recently been given the Hero Award for outstanding dedication to pediatric neuro-oncology by the Pediatric Brain Tumor Foundation, and was named one of Chicago’s Top Cancer Doctors by Chicago magazine.

Dr. Lulla’s scientific work has been published in more than 20 peer-reviewed journals and two books. He has presented his findings on pediatric central nervous system tumors at the local, national, and international levels, and he has served as principal investigator to multiple grant-sponsored research investigations. His current research activities are focused on translating laboratory findings into novel treatment for children with brain and spinal cord tumors. He served as the executive chair of the Children’s Brain Tumor Tissue Consortium and is an active member of the American Society of Pediatric Hematology Oncology, the Children’s Oncology Group, and the Society of Neuro-Oncology.

Radiation Oncology

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Director of Stereotactic Radiosurgery

Jaroslaw T. Hepel, MD, serves as director of stereotactic radiosurgery at Rhode Island Hospital and as an assistant professor at The Warren Alpert Medical School of Brown University. He also serves as associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. He is board certified in radiation oncology by the American Board of Radiology. Hepel received his undergraduate degree at Cornell University and earned his medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA. 

Hepel has broad experience and knowledge, and is active in caring for patients with a wide range of malignant diseases. However, he holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the lung, brain, spine, liver and other sites. He is not only very active in the clinic but also has a keen academic interest in these areas. He has published several book chapters and multiple scientific papers, and has regularly presented his work at national meetings. Through his academic work, he strives to improve treatment outcomes for patients not only in regard to achieving higher cure rates but also to minimizing treatment side effects.

Oncologist-in-Chief, Radiation Oncology

David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.

Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.

Pathology

Pathologist-in-Chief

Douglas C. Anthony, MD, PhD is chief of pathology at Rhode Island and The Miriam hospitals.

Anthony served as chair of the department of pathology and anatomical sciences and professor of neurology at the University of Missouri. At the University of Missouri Health Care he served as chief of pathology and medical director of pathology clinical laboratories. He also served as a pathologist at the Harry S. Truman Veterans Administration Medical Center, Women and Children's Hospital, and the Ellis Fischel Cancer Center, and as a neuropathologist for the Office of the Medical Examiner in Boone, Callaway and Greene counties in Missouri. Previously, he was on the faculty at Harvard Medical School and served as a neuropathologist at Boston Children's Hospital, Brigham and Women's Hospital, and as a neuropathologist consultant to the Office of the Chief Medical Examiner for the Commonwealth of Massachusetts.

Anthony earned his bachelor's degree in chemical engineering from Washington University in St. Louis, Mo.; his doctoral degree in experimental pathology from Duke University; and his medical degree from Duke University. He completed his residency in pathology and a fellowship in neuropathology at Duke University Medical Center.

He is a member of the United States and Canadian Academy of Pathology; the American Association of Neuropathologists; the College of American Pathologists; the Society for Neuroscience; Society of Toxicology; and the American Society for Neurochemistry, among others. He has served on several editorial boards, including the Journal of Neuropathology and Experimental Neurology; Advances in Anatomic Pathology; and Pediatric Pathology and Molecular Medicine, and is an author of the neuroscience sections of Robbins and Cotran Pathologic Basis of Disease. He has won numerous awards, including the Dr. Edison H. and Sallie Y. Miyawaki Teaching Award in Neurosciences at Harvard Medical School; the Excellence in Education Award in pre-clinical sciences at the University of Missouri; and the Order of Socrates award at the School of Medicine at the University of Missouri.

Anthony's research interests include the biology of axons and its relevance to diseases of peripheral nerves, and the pathobiology of brain tumors.

Neuropathologist

John E. Donahue, MD, is a neuropathologist at Rhode Island Hospital. In his 25 years studying and working as a medical professional, Dr. Donahue has received accreditation as a lead or co-author in over 40 articles published in highly rated scientific journals. He is an associate professor at The Warren Alpert Medical School of Brown University, and teaches fellows of Rhode Island Hospital in the field of neuropathology. He has received multiple awards and certificates of recognition at The Warren Alpert Medical School for his dedication and distinction as a professor.

Dr. Donahue is an active member of several professional societies, including the American Association of Neuropathologists, the American Academy of Neurology and the Rhode Island Neurological Society.

Director of Immunohistochemistry, Lifespan Laboratories

Jesse L. Hart, DO, specializes in pathology at Rhode Island Hospital, and serves as director of immunohistochemistry for Lifespan Laboratories. He has taught as an invited lecturer at The Warren Alpert Medical School at Brown University and at the University of Rhode Island. He has given many lectures at the hospital during the microscopic slide conferences, and received the Golden Apple Award for Excellence in Teaching for his dedication and skill in the field.

Dr. Hart is also an author in several original publications and peer-reviewed journals. He is an active member of the Rhode Island Society of Pathologists and the College of American Pathologists.

Diagnostic Imaging/Neuroradiology

Diagnostic Neuroradiologist

Jerrold L. Boxerman, MD, PhD, FACR, specializes in diagnostic neuroradiology at Rhode Island Hospital. He is both a guest lecturer and associate professor of diagnostic imaging at The Warren Alpert Medical School of Brown University. He serves as medical director of the MRI Research Facility at Brown University, which is affiliated with the university's Institute for Brain Science. Dr. Boxerman is also co-chair for neuroradiology for the radiology committee of the Brown University Oncology Group, and is a fellow of the American College of Radiology.

Dr. Boxerman’s published work includes more than 50 peer-reviewed papers and seven book chapters, and he currently serves as a reviewer for multiple academic radiology journals. His research focus includes perfusion-weighted MRI for characterizing and determining the treatment response of brain tumors. Dr. Boxerman is a senior member of the American Society of Neuroradiology and holds a certificate of additional qualification in neuroradiology. He frequently provides neuroradiology expertise at clinical conferences at Rhode Island Hospital.

Neuroradiologist

Richard A. Haas, MD, a neuroradiologist at Rhode Island Hospital, is board certified in diagnostic radiology, neuroradiology, and vascular and interventional radiology. He is an associate professor of diagnostic radiology and neurosurgery at The Warren Alpert Medical School of Brown University, and has been teaching at the university level for many years.

Dr. Haas’s work has been published in more than 20 peer-reviewed publications. He has participated in several scientific experiments that have been displayed at various medical conferences and assemblies. He is a member of is the Radiological Society of North America and the New England Society of Cardiovascular and Interventional Radiology.

Director of the Neurovascular Center, Rhode Island Hospital

Mahesh V. Jayaraman, MD is a neuroradiologist who specializes in interventional neuroradiology at Rhode Island Hospital. He is an associate professor of diagnostic imaging, neurology and neurosurgery at The Warren Alpert Medical School of Brown University. He is also the director of the Neurovascular Center at Rhode Island Hospital.

Dr. Jayaraman’s research interest is in the minimally invasive therapy of neurovascular disease, including acute ischemic stroke. His work has been published in more than 90 peer-reviewed journals, books and book chapters. He is a senior member of the American Society of Neuroradiology and the Society of NeuroInterventional Surgery. 

Director of Interventional Neuroradiology
Twitter: @mobilestroke4U
 

Ryan A. McTaggart, MD, is the director of interventional neuroradiology at Rhode Island Hospital and an assistant professor of diagnostic imaging, neurology, and neurosurgery at The Warren Alpert Medical School of Brown University.

Dr. McTaggart’s work has been published in over fifty peer-reviewed journals and he is the author of “Image-guided Ablation in the Thorax,” a chapter in a textbook about interventional oncology and cancer therapy. He has presented regionally and internationally on a variety of topics but is particularly  interested in discussing improving systems of care for patients with acute stroke.

In addition to his university teaching roles, Dr. McTaggart also instructs residents and fellows in neuroradiology and diagnostic imaging at Rhode Island Hospital. He is a senior member of the Society of NeuroInterventional Surgery, American Heart Association, and the American Society of Neuroradiology. He serves on the Standards and Guidelines Committee for the Society of Neurointerventional Surgery.

Director of Neuroradiology and Medical Director of Magnetic Resonance Imaging, Rhode Island Hospital

Jeffrey M. Rogg, MD, is director of neuroradiology and medical director of magnetic resonance imaging at Rhode Island Hospital. He is also an associate professor of diagnostic imaging at The Warren Alpert Medical School of Brown University, where he teaches cross-sectional imaging and neuroradiology. Dr. Rogg has been named as a featured “Best Doctor” by Rhode Island Monthly eight times.

Dr. Rogg has received many grants to pursue innovations in the medical field; he was the principal investigator of a study on concussions in athletes and an experiment concerning Gadovist safety and efficacy. In addition, his work has been published in several peer-reviewed journals and other publications. He is currently a member of the board of directors for the American Board for Magnetic Resonance Imaging Safety and a senior member of the American Society of Neuroradiology.

Breast Cancer

Medical Oncology

Director of Women's Cancers, Lifespan Cancer Institute, Clinical Director, Gynecologic Medical Oncology and Director of Medical Oncology, Rhode Island Hospital

Don S. Dizon, MD, FACP, FASCO, is an oncologist who specializes in women's cancers. He is the director of women's cancers at Lifespan Cancer Institute and director of medical oncology at Rhode Island Hospital. He is also a professor of medicine at The Warren Alpert Medical School of Brown University. His research interests are in novel treatments of women’s cancers and issues related to survivorship, particularly as they relate to sexual health after cancer for both men and women.

He is a prolific researcher and writer, and he has authored hundreds of publications, including peer-reviewed articles, books and book chapters. He is an active member of the American Society of Clinical Oncology, SWOG cancer research network, and the National Consortium of Breast Cancers, of which he has served as both vice president and president. 

Clinical Director, Breast Medical Oncology at Rhode Island Hospital

Mary Ann Fenton, MD, FACP is an oncologist at the Lifespan Cancer Institute and a clinical associate professor at The Warren Alpert Medical School of Brown University. Her specialty area is the prevention and treatment of breast cancer.

Oncologist

Mary L. Lopresti, DO, is an oncologist who specializes in breast and gynecological cancers at Rhode Island Hospital and Lifespan Cancer Institute. She serves as assistant professor of hematology oncology at The Warren Alpert Medical School of Brown University, and is also an assistant program director of the Brown University hematology oncology fellowship program.

Dr. Lopresti is currently involved in breast cancer research studies at Brown University and Rhode Island and The Miriam hospitals. Her  work has been published in several peer-reviewed journals, books and book chapters. She is a member of the American Society of Hematology and the American Society of Clinical Oncology.

Clinical Director, Women’s Medical Oncology at The Miriam Hospital
Hematologist/Oncologist

Sabrina M. Witherby, MD, is a hematologist/oncologist at Lifespan Cancer Institute. She is an assistant professor of medicine at The Warren Alpert Medical School of Brown University. She specializes in breast cancer and hematology and has particular interest in geriatric oncology, supportive care in oncology and medical education.

Dr. Witherby was named one of Rhode Island Monthly’s Top Docs in 2017 and awarded the Beckwith Family Teaching Award from The Warren Alpert Medical School of Brown University in 2013. She is a member of the American Society of Clinical Oncology, the Massachusetts Medical Society, and the Association of Program Directors in Internal Medicine. 

Radiation Oncology

Director of Stereotactic Radiosurgery

Jaroslaw T. Hepel, MD, serves as director of stereotactic radiosurgery at Rhode Island Hospital and as an assistant professor at The Warren Alpert Medical School of Brown University. He also serves as associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. He is board certified in radiation oncology by the American Board of Radiology. Hepel received his undergraduate degree at Cornell University and earned his medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA. 

Hepel has broad experience and knowledge, and is active in caring for patients with a wide range of malignant diseases. However, he holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the lung, brain, spine, liver and other sites. He is not only very active in the clinic but also has a keen academic interest in these areas. He has published several book chapters and multiple scientific papers, and has regularly presented his work at national meetings. Through his academic work, he strives to improve treatment outcomes for patients not only in regard to achieving higher cure rates but also to minimizing treatment side effects.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, her master of science from Villanova University in Villanova, Pennsylvania, and her medical degree from Albany Medical College in Albany, New York. She completed an internship in internal medicine at Albany Medical Center, followed by a residency in radiation oncology at Tufts Medical Center in Boston. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Oncologist-in-Chief, Radiation Oncology

David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Radiation Oncologist

Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.

Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.

Surgical Oncology

Surgical Oncologist

Christine Emmick, MD is a board-certified general surgeon who cares for a wide array of surgical diseases. She received her medical degree from the Albany Medical College and completed her surgical residency at The Warren Alpert Medical School of Brown University and Rhode Island Hospital.

Dr. Emmick has a special interest in the treatment of both benign and malignant breast disease and is a member of the Lifespan Cancer Institute's multidisciplinary breast clinic team at The Miriam Hospital. She is an assistant clinical professor of surgery at The Warren Alpert Medical School of Brown University and a member of the American College of Surgeons.

More about the Lifespan Cancer Institute »

Director, Breast Cancer Center of the Lifespan Cancer Institute
General Surgeon

Bradford Gray, MD, FACS, is a board-certified general surgeon affiliated with Newport Hospital. Dr. Gray received his medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania, and completed his resident training at Abington Memorial Hospital in Abington, Pennsylvania. He is a fellow of the American College of Surgeons. Dr. Gray has interest and expertise across a broad range of surgical services, including management of benign and malignant breast conditions; thyroid surgery; endoscopic procedures; management of malignant skin conditions, including melanoma; and advanced laparoscopic surgery, including hernia repair, colon surgery and foregut surgery.

Associate Director, Breast Cancer Multidisciplinary Clinic at Newport Hospital

Julia Tassinari, MD, is a board-certified general surgeon and the associate director of the Lifespan Cancer Institute Breast Cancer Multidisciplinary Clinic at Newport Hospital.  Dr. Tassinari received her medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania, and completed her internship and residency at St. Elizabeth’s Medical Center in Boston, Massachusetts. Among her interests and expertise are minimally invasive surgery, including hernia repair, colon and foregut surgery; breast surgery; and skin and soft tissue surgery.

Surgical Oncologist

Charu Taneja, MD, is an affiliated surgical oncologist in the High-Risk Breast Program at the Women's Medicine Collaborative. She is a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. She received her medical degree from Maulana Azad Medical College, University of Delhi in New Delhi, India. Taneja completed a residency in surgery at the University of Medicine and Dentistry at New Jersey Medical School in Newark, New Jersey. She is a graduate of the surgical oncology fellowship at Boston University.

Taneja is board certified in surgery. She has published many original research articles in the field of oncology and breast surgery.

Director, Cancer Survivorship Program

Doreen Wiggins, MD, MHL, FACOG, FACS, is an affiliated physician at the Women's Medicine Collaborative. She is director of the Cancer Survivorship Medicine program and is an assistant clinical professor at The Warren Alpert Medical School of Brown University.

She received her undergraduate degree from the University of Rhode Island and her medical degree from The Warren Alpert Medical School of Brown University. She pursued further medical training at Women & Infants Hospital and completed a Society for Surgical Oncology Breast Disease fellowship, and an intensive course in cancer risk assessment at the City of Hope in Los Angeles, California. Wiggins earned a master’s degree in healthcare leadership from The Warren Alpert Medical School of Brown University.

Wiggins is a fellow of both the American College of Obstetrics and Gynecology and the American College of Surgeons. She is the founder of Center for Obstetrics & Gynecology in Providence. Her areas of expertise are breast cancer surgery, gynecologic surgery, female cancer genetics, female sexuality and cancer survivorship.

Colorectal Cancer

Medical Oncology

Oncologist

Khaldoun Almhanna, MD, MPH, is a gastrointestinal oncologist at the Lifespan Cancer Institute, specializing in hematology and oncology. Dr. Almhanna earned his medical degree from Damascus University in Syria and a master of public health degree from Case Western Reserve University in Cleveland. His research interests include esophageal cancer and gastrointestinal malignancies. He is a member of the American Medical Association, the American Diabetes Association and the American Society of Clinical Oncology. He is fluent in English, Arabic and French.

Hematologist/Oncologist

Rimini A. Breakstone, MD is a medical oncologist who specializes in gastrointestinal cancers. She received her medical degree from the Robert Wood Johnson Medical School at Rutgers University and completed her residency and fellowship at The Warren Alpert Medical School of Brown University. Dr. Breakstone is board certified in hematology, oncology and internal medicine.

Prior to joining the Lifespan Cancer Institute, she was an instructor at the Hospital of the University of Pennsylvania and served on the Unit Based Clinical Leadership Committee focused on inpatient quality improvement measures. Dr. Breakstone is a member of the American Society of Clinical Oncology and the American Medical Association. Her research interests include malignancies of esophagus, stomach, biliary system, pancreas, colon and rectum.

Hematologist/Oncologist

Alexander G. Raufi, MD, is a hematologist/oncologist at the Lifespan Cancer Institute at Rhode Island and The Miriam hospitals, where he specializes in gastrointestinal oncology. Dr. Raufi received his medical degree from The Warren Alpert Medical School of Brown University and completed his residency in internal medicine at the University of California Irvine. He performed his fellowship in hematology/oncology at Columbia University/New York-Presbyterian. His research interests include the development of novel immunotherapy combinations in gastrointestinal malignancies. Dr. Raufi is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research.

Chief, Hematology Oncology

Howard P. Safran, MD is the chief of hematology/oncology at the Lifespan Cancer Institute at Rhode Island, The Miriam and Newport hospitals, and the medical director for the Brown University Oncology Group. Safran is a professor of medicine at The Warren Alpert Medical School of Brown University and a nationally recognized leader in the development of new treatments for upper GI cancers. He is a member of the U.S. National Cancer Institute's pancreatic and gastrointestinal cancer task forces.

Surgical Oncology

Colorectal Surgeon

Adam Klipfel, MD, FACS, FASCRS, is a board-certified, fellowship-trained colorectal surgeon with expertise in colon cancer and surgical oncology. He received his medical degree from Mount Sinai School of Medicine in New York and completed a residency at New York Methodist Hospital. Dr. Klipfel gained further experience through a colorectal fellowship and an anorectal physiology fellowship at University of Southern California-affiliated hospitals. He has expertise in robotic surgery for benign and malignant disease. He is a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University and is program coordinator of the Colorectal Surgery Fellowship program. Dr. Klipfel is the current president of the Rhode Island Chapter of the American College of Surgeons. He is a fellow of the American College of Surgeons and the American Society of Rectal and Colon Surgeons as well as a member of Society for Surgery of the Alimentary Tract and the New England Society of Colon and Rectal Surgeons, among others.

Colorectal Surgeon and Co-Director, Program for Pelvic Floor Disorders, Women’s Medicine Collaborative

Leslie Roth, MD, FACS, FASCRS is co-director of the Program for Pelvic Floor Disorders in the Center for Women’s Gastrointestinal Medicine at the Women’s Medicine Collaborative and a colorectal surgeon at University Surgical Associates.

Dr. Roth is the Rosalyn and Joseph Sinclair Clinical Professor of Pelvic Floor Disorders and an assistant professor of surgery at The Warren Alpert Medical School of Brown University. She received her undergraduate degree from the University of Arizona and her medical degree from the Tel Aviv University Sackler School of Medicine, New York State/American Program, in Ramat Aviv, Israel and New York.

She completed her residency at Penn State Milton S. Hershey Medical Center. She is a graduate of the colon and rectal surgery fellowship at the University of Louisville in Kentucky. Dr. Roth is board certified in both general and colorectal surgery. She is also a fellow of both the American College of Surgeons and the American Society of Colon and Rectal Surgeons.

Dr. Roth's areas of clinical interest and expertise include colon and rectal cancer surgery, colonoscopy, laparoscopic/minimally invasive surgery, benign anorectal conditions, fecal incontinence and other pelvic floor disorders.

Interim Chief of Colorectal Surgery for Lifespan

Steven Schechter, MD, is the interim chief of colorectal surgery for Lifespan and a board-certified colorectal surgeon with special expertise in laparoscopic, minimally invasive surgery, fecal incontinence, pelvic floor reconstructive surgery, and colon cancer.

His research interests include rectal cancer treatment, and the link between anal cancer and human papilloma virus in women.

Dr. Schechter is a fellow of the American College of Surgeons, the American Society of Colon and Rectal Surgeons, and the New England Surgical Society of Colon and Rectal Surgeons, and a member of the International Society of Laparoscopic Colorectal Surgery.

Dr. Schechter is a member of Phi Beta Kappa and recipient of several awards for his teaching at The Warren Alpert Medical School of Brown University, where he is a clinical associate professor.

Director of General Surgery, The Miriam Hospital

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, her master of science from Villanova University in Villanova, Pennsylvania, and her medical degree from Albany Medical College in Albany, New York. She completed an internship in internal medicine at Albany Medical Center, followed by a residency in radiation oncology at Tufts Medical Center in Boston. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Radiation Oncologist

Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.

Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.

Gastrointestinal Cancer

Medical Oncology

Oncologist

Khaldoun Almhanna, MD, MPH, is a gastrointestinal oncologist at the Lifespan Cancer Institute, specializing in hematology and oncology. Dr. Almhanna earned his medical degree from Damascus University in Syria and a master of public health degree from Case Western Reserve University in Cleveland. His research interests include esophageal cancer and gastrointestinal malignancies. He is a member of the American Medical Association, the American Diabetes Association and the American Society of Clinical Oncology. He is fluent in English, Arabic and French.

Hematologist/Oncologist

Rimini A. Breakstone, MD is a medical oncologist who specializes in gastrointestinal cancers. She received her medical degree from the Robert Wood Johnson Medical School at Rutgers University and completed her residency and fellowship at The Warren Alpert Medical School of Brown University. Dr. Breakstone is board certified in hematology, oncology and internal medicine.

Prior to joining the Lifespan Cancer Institute, she was an instructor at the Hospital of the University of Pennsylvania and served on the Unit Based Clinical Leadership Committee focused on inpatient quality improvement measures. Dr. Breakstone is a member of the American Society of Clinical Oncology and the American Medical Association. Her research interests include malignancies of esophagus, stomach, biliary system, pancreas, colon and rectum.

Hematologist/Oncologist

Alexander G. Raufi, MD, is a hematologist/oncologist at the Lifespan Cancer Institute at Rhode Island and The Miriam hospitals, where he specializes in gastrointestinal oncology. Dr. Raufi received his medical degree from The Warren Alpert Medical School of Brown University and completed his residency in internal medicine at the University of California Irvine. He performed his fellowship in hematology/oncology at Columbia University/New York-Presbyterian. His research interests include the development of novel immunotherapy combinations in gastrointestinal malignancies. Dr. Raufi is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research.

Chief, Hematology Oncology

Howard P. Safran, MD is the chief of hematology/oncology at the Lifespan Cancer Institute at Rhode Island, The Miriam and Newport hospitals, and the medical director for the Brown University Oncology Group. Safran is a professor of medicine at The Warren Alpert Medical School of Brown University and a nationally recognized leader in the development of new treatments for upper GI cancers. He is a member of the U.S. National Cancer Institute's pancreatic and gastrointestinal cancer task forces.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, her master of science from Villanova University in Villanova, Pennsylvania, and her medical degree from Albany Medical College in Albany, New York. She completed an internship in internal medicine at Albany Medical Center, followed by a residency in radiation oncology at Tufts Medical Center in Boston. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Radiation Oncologist

Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.

Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.

Surgical Oncology

Surgeon

Rachel E. Beard, MD, is fellowship trained in surgical oncology and in surgery of the liver, pancreas, and biliary tract. She is an assistant professor of surgery at The Warren Alpert Medical School of Brown University. Her research focuses on minimally invasive approaches to liver and pancreas surgery, and immunotherapy for the treatment of widespread malignancies.

Thoracic Surgeon

Steven Milman, MD, is a board-certified general and thoracic surgeon and a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. He earned his medical degree from Cornell University Medical College, followed by a residency at Rhode Island Hospital. Dr. Milman completed a fellowship at Rush University Medical Center.

His clinical interests include endobronchial therapy and esophageal stenting for palliation of intrathoracic malignancies.

Chief of Surgical Oncology, Rhode Island Hospital

Thomas Miner, MD, is chief of surgical oncology at Rhode Island Hospital. He is an associate professor of surgery at The Warren Alpert Medical School of Brown University and an expert in gastric cancer surgery.

Dr. Miner's research interests include the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers with diffuse involvement of the abdominal cavity.

Director, Division of Thoracic Surgery

Thomas Ng, MD, is a thoracic surgeon at Rhode Island Hospital and is an associate professor of surgery at The Warren Alpert Medical School of Brown University. Ng received his bachelor’s degree from the University of Toronto and his medical degree from Queen’s University School of Medicine in Kingston, Canada. He completed his residency in general surgery at The Warren Alpert Medical School of Brown University, a fellowship in critical care medicine at the University of Toronto and a fellowship in thoracic surgery at the University of Ottawa. Ng is active in a number of societies, including the American College of Surgeons, Canadian Association of Thoracic Surgeons, Cancer and Leukemia Group B, New England Surgical Society, Rhode Island Medical Society, Royal College of Surgeons of Canada, Society of Surgical Oncology and Society of Thoracic Surgeons.

Genetics

Clinical Geneticist

Lauren Massingham, MD is with the division of genetics at Hasbro Children’s Hospital; she is also an assistant professor of pediatrics at The Warren Alpert Medical School of Brown University. Dr. Massingham is board certified in pediatrics and clinical genetics. Her clinical interests include all aspects of pediatric genetics, with specific focus on pediatric genetics and cancer genetics. Her research interests include gene expression profiling of Turner syndrome and Down syndrome. She is a member of the American Academy of Pediatrics and Genetics Teleconference Feingold Center. 

Dr. Massingham received her medical degree from the University of Vermont College of Medicine in Burlington, VT. She completed a residency in pediatrics at University of Massachusetts Memorial Medical Center in Worcester, MA as well as a residency in medical genetics at Tufts University School of Medicine in Boston, MA. 

Director, Division of Genetics

Chanika Phornphutkul, MD, is the director of human genetics at Rhode Island and its Hasbro Children’s Hospital, and is an associate professor of pediatrics at The Warren Alpert Medical School of Brown University. She provides genetic risk assessment as well as counseling for patients with a family history of genetic disorders. She is board certified in pediatric endocrinology and biochemical genetics.

Dr. Phornphutkul received her medical degree from the Chiang Mai University School of Medicine in Thailand, and completed her residency at Mott Children’s Hospital in Ann Arbor, Michigan and Hasbro Children’s Hospital in Providence, Rhode Island. She completed a fellowship at Hasbro Children’s Hospital and the National Institutes of Health in Bethesda, Maryland. Her clinical and research interests focus on biochemical genetics (metabolic disorders), the application of genomic information in clinical medicine and newborn screening.

View the Brown University biography page for Chanika Phornphutkul, MD

Gynecologic Oncology

Medical Oncology

Director of Women's Cancers, Lifespan Cancer Institute, Clinical Director, Gynecologic Medical Oncology and Director of Medical Oncology, Rhode Island Hospital

Don S. Dizon, MD, FACP, FASCO, is an oncologist who specializes in women's cancers. He is the director of women's cancers at Lifespan Cancer Institute and director of medical oncology at Rhode Island Hospital. He is also a professor of medicine at The Warren Alpert Medical School of Brown University. His research interests are in novel treatments of women’s cancers and issues related to survivorship, particularly as they relate to sexual health after cancer for both men and women.

He is a prolific researcher and writer, and he has authored hundreds of publications, including peer-reviewed articles, books and book chapters. He is an active member of the American Society of Clinical Oncology, SWOG cancer research network, and the National Consortium of Breast Cancers, of which he has served as both vice president and president. 

Oncologist

Mary L. Lopresti, DO, is an oncologist who specializes in breast and gynecological cancers at Rhode Island Hospital and Lifespan Cancer Institute. She serves as assistant professor of hematology oncology at The Warren Alpert Medical School of Brown University, and is also an assistant program director of the Brown University hematology oncology fellowship program.

Dr. Lopresti is currently involved in breast cancer research studies at Brown University and Rhode Island and The Miriam hospitals. Her  work has been published in several peer-reviewed journals, books and book chapters. She is a member of the American Society of Hematology and the American Society of Clinical Oncology.

Clinical Director, Women’s Medical Oncology at The Miriam Hospital

Radiation Oncology

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board-certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, Massachusetts, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity-modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Surgical Oncology

Chief of Obstetrics and Gynecology, Rhode Island and The Miriam Hospitals

Christina A. Bandera, MD, is a gynecologic oncologist and director of the Center for Gynecologic Cancers at the Women’s Medicine Collaborative, and chief of obstetrics and gynecology at The Miriam Hospital and Rhode Island Hospital. Dr. Bandera received her undergraduate degree from Harvard University, and her medical degree from Johns Hopkins University School of Medicine. She completed her postgraduate training at Brigham and Women’s Hospital and Massachusetts General Hospital, and held fellowships at the University of Pennsylvania School of Medicine and the Mayo Clinic Hospital in Phoenix, Arizona.

Dr. Bandera is board certified in obstetrics and gynecology, and gynecologic oncology. She served as director of robotic surgery at Women & Infants Hospital, and is a member of the Society of Gynecologic Oncologists and the American Association for Gynecologic Laparoscopy.

Dr. Bandera’s clinical expertise includes the medical and surgical treatment of gynecologic cancers arising from the uterus, ovary, cervix, vagina and vulva, as well as the treatment of molar pregnancies and conditions resulting in abnormal pap smears. She has a special interest in cancer prevention and minimally invasive cancer surgery, including robotic surgery.

Gynecologic Oncologist

Tarra Evans, MD, is a gynecologic oncologist in the Center for Gynecologic Cancer at the Women’s Medicine Collaborative. She is a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. Dr. Evans is a member of the Society of Gynecologic Oncologists and has expertise in the surgical and medical treatment of precancers and cancers of the ovary, uterus, cervix, vagina and vulva, with a special interest in surgeries to alleviate cancer-related symptoms. She is fellowship trained in addressing complex cancer-related symptoms and completed the Harvard Interprofessional Palliative Care Fellowship at Massachusetts General Hospital and Dana-Farber Cancer Institute.

Head and Neck / Thyroid Center

Medical Oncology

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Palliative Care

Palliative Care Physician

Dana Levy Guyer, MD, is a palliative care physician at Lifespan Cancer Institute and Rhode Island Hospital. She received her medical degree from Vanderbilt University School of Medicine. She completed her residency training in internal medicine and pediatrics, as well as her fellowship in palliative care and hospice, at Vanderbilt University Medical Center. She is board certified in hospice and palliative medicine, internal medicine, and pediatric medicine, and is a member of the American Academy of Hospice and Palliative Medicine.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, her master of science from Villanova University in Villanova, Pennsylvania, and her medical degree from Albany Medical College in Albany, New York. She completed an internship in internal medicine at Albany Medical Center, followed by a residency in radiation oncology at Tufts Medical Center in Boston. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board-certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, Massachusetts, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity-modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Radiation Oncologist

Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.

Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.

Surgical Oncology

Surgeon

Dr. Cotton is an endocrine surgeon who specializes in the surgical management of both benign and malignant diseases of the thyroid, parathyroid, adrenal, and endocrine pancreas. Originally from Texas, Dr. Cotton graduated Summa Cum Laude with a B.S. in Biomedical Science from Texas A&M University. He went on to receive his medical degree from the University of Texas at San Antonio School of Medicine with Alpha Omega Alpha honors. He then completed his internship and residency in general surgery at the University of North Carolina in Chapel Hill, NC. He subsequently became the Norman W. Thompson Fellow of Endocrine Surgery at the University of Michigan where he completed his endocrine surgery fellowship.

Dr. Cotton’s practice is primarily dedicated to taking care of patients with thyroid, parathyroid, and adrenal disease. He has expertise in thyroid ultrasound and ultrasound-guided thyroid FNA biopsies which are frequently performed in the office. He performs standard endocrine operations as well as minimally invasive parathyroidectomy and laparoscopic adrenalectomy.

Dr. Cotton’s research interests include parathyroid disease, papillary thyroid cancer, and thyroid ultrasound. He additionally participates in the education of both medical students and surgical residents at the Warren Alpert Medical School of Brown University.

Surgeon

Peter J. Mazzaglia, MD, is associate professor of surgery in the division of endocrine surgery at Rhode Island Hospital and the Warren Alpert School of Medicine at Brown University. Mazzaglia completed his residency in internal medicine at Dartmouth Hitchcock Medical Center and practiced internal medicine for three years in Portland, Maine prior to beginning his surgical training.

After his surgical residency at Maine Medical Center, Mazzaglia completed an additional year of endocrine surgery fellowship at the Cleveland Clinic in Ohio, where he specialized in surgery of the thyroid, parathyroid, adrenal and pancreas. As part of this fellowship, he gained expertise in the field of surgeon-performed ultrasound. He has been certified by the American College of Surgeons as an ultrasound instructor. Thyroid and parathyroid ultrasound, as well as ultrasound-guided thyroid FNA biopsy, is now an integral part of his practice. Unique to his fellowship training at the time was also specialized instruction in the performance of retroperitoneal laparoscopic adrenalectomy. When he came to Providence in 2006, he was the first surgeon in New England to routinely use this approach for adrenalectomy.

Research Highlights

  • The Changing Presentation of Hyperparathyroidism Over Three Decades. Mazzaglia P J, Berber E, Siperstein A E, Milas K M.  Archives of Surgery. 2008 Mar;143(3):260-6. 
     
  • Limited Value of adrenal biopsy in the evaluation of adrenal incidentaloma: A Decade of Experience.  Mazzaglia PJ, Monchik JM.  Archives of Surgery. 2009 May;144(5):465-70. 
     
  • Surgeon-performed ultrasound in patients referred for thyroid disease improves patient care by minimizing performance of unnecessary procedures, and optimizing surgical treatment. Mazzaglia PJ. WorldJournal of Surgery. 2010 Jun;34(6):1164-70. 
     
  • Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer. Yoo D, Ajmal S, Gowda S, Machan J, MonchikM, Mazzaglia PJ. World J Surg. 2012 Jun;36(6):1255-61. 
     
  • The Benign Thyroid Nodule: What is the appropriate follow-up strategy? Ajmal S, Rapoport S, Ramirez Battle H, Mazzaglia P. epubJournal of the American College of Surgeons. 2015 Jan. 

Otolaryngologist-Head and Neck Surgeon

Richard Wein, MD is an otolaryngologist-head and neck surgeon at the Lifespan Cancer Institute. He earned his medical degree from Tufts University School of Medicine in Boston. He completed his otolaryngology-head and neck surgery residency at the University of Rochester Medical Center and subsequently completed his fellowship in head and neck surgical oncology at the University of Pennsylvania Health System.

Dr. Wein specializes in surgical management and reconstruction for patients requiring care for tumors of the head and neck.

Hematology

Hematologist Oncologist

Peter M. Barth, MD, is a hematologist/oncologist at Lifespan Cancer Institute who specializes in the treatment of benign and malignant blood disorders. He completed his residency at Temple University Hospital in Philadelphia and his fellowship at Rhode Island Hospital with Brown University. He has presented his work on platelet disorders and blood count abnormalities on a national level. His research interests are in the treatment of plasma cell neoplasms such as multiple myeloma. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the International Myeloma Society and the American Medical Association.

Hematologist Oncologist

James N. Butera, MD, is a board-certified hematologist/oncologist who treats patients with blood disorders including bleeding and clotting problems, leukemia, lymphoma, and multiple myeloma. He sees patients at the Lifespan Cancer Institute at Rhode Island Hospital and the Lifespan Ambulatory Care Center in East Greenwich. He is a clinical associate professor of medicine at The Warren Alpert Medical School of Brown University.

Dr. Butera’s research findings have been published in numerous peer-reviewed journals, and he is the site principal investigator at Lifespan for several chemotherapy studies. Among other honors, Dr. Butera has received the Brown University Dean’s Excellence in Teaching Award multiple times and been named one of Rhode Island Monthly magazine’s Top Docs for several years.

Hematologist/Oncologist

Pamela C. Egan, MD, is a hematologist at Rhode Island Hospital. Her interests include the treatment of acute leukemia, palliative care in hematologic malignancies, and physician advocacy education. She earned her medical degree from SUNY Upstate School of Medicine in Syracuse, New York, and completed her residency and fellowship at Rhode Island Hospital and The Warren Alpert Medical School of Brown University. Dr. Egan is a member of the American Society of Hematology and The American College of Physicians.

Hematologist/Oncologist

Rabin Niroula, MD, is a board-certified hematologist/oncologist at the Lifespan Cancer Institute. He earned his medical degree from Sher-e-Bangla Medical College of Dhaka University in Bangladesh. He completed his residency in internal medicine at Saint Vincent Hospital and University of Massachusetts Medical School, where he was named chief resident. He completed a fellowship in hematology/oncology at Roger Williams Medical Center and The Warren Alpert Medical School of Brown University. 

Dr. Niroula specializes in internal medicine. His clinical interests include astrocytoma, neuroblastoma, and mycosis fungoides. His work has been published in peer reviewed journals, book chapters and abstracts. 
 

Hematologist/Oncologist

Thomas A. Ollila, MD, is an hematologist/oncologist at Lifespan Cancer Institute. He earned his medical degree from Drexel University College of Medicine, and completed his residency in internal medicine and fellowship in hematology/oncology at Rhode Island Hospital. Dr. Ollila´s research interests include translational and clinical outcomes in lymphoma as well as addressing opioid use in cancer patients and survivors. In 2018, he was given the Conquer Cancer Foundation Merit Award by the American Society of Clinical Oncology. He is a member of the Alpha Omega Alpha Medical Honors Society, the American Society of Hematology and the American Society of Clinical Oncology.

Hematologist/Oncologist

Adam Olszewski, MD is a board-certified clinical hematologist/oncologist and researcher with the Lifespan Cancer Institute at Rhode Island Hospital. Dr. Olszewski is also an assistant professor of clinical medicine at The Warren Alpert Medical School of Brown University. He previously served as a cancer committee chair member and clinical oncologist/hematologist at the Cancer Center at Memorial Hospital of Rhode Island. Dr. Olszewski was also a physician director of outpatient infusion services at Kent County Hospital. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Hematologist Oncologist
Adult Hematologist Oncologist
Hematologist/Oncologist
Associate Physician-in-Chief, The Miriam Hospital; Medical Director, Lifespan Cancer Institute
Hematologist/Oncologist

Robert Sokolic, MD, FACP, is a hematologist and oncologist at Lifespan Cancer Institute. He is a member of the sickle cell disease multidisciplinary team and specializes in primary disorders of bone marrow. His research interests include sickle cell disease and primary immunodeficiency diseases. His work has been published in many scientific journals and book chapters, including the New England Journal of Medicine. He is a member of the American Society of Hematology, Clinical Immunology Society, the American Society of Cell and Gene Therapy and the American Society for Blood and Marrow Transplantation.

Immunology

Interventional Oncology

Director, Interventional Radiology, Rhode Island Hospital

Gregory Dubel, MD, FSIR, is a vascular radiologist who specializes in the administration of small particles that deliver radiation directly into liver tumors that cannot be surgically removed. He is an Assistant Professor of Diagnostic Imaging at The Warren Alpert Medical School of Brown University.

Director, Thoracic Radiology, Rhode Island Hospital

Terrance T. Healey, MD, director of thoracic radiology at Rhode Island Hospital, received a medical degree from the combined Dartmouth-Brown program. He completed his residency at Rhode Island Hospital and The Warren Alpert Medical School of Brown University, and thoracic radiology fellowship at Massachusetts General Hospital and Harvard Medical School. He is an assistant professor of diagnostic imaging at The Warren Alpert Medical School of Brown University. Healey’s area of expertise involves using image-guided thermal ablation to treat lung tumors.

Director, Interventional Oncology

Jason Iannuccilli, MD, is a radiologist with particular interest in vascular and interventional radiology. He specializes in both transarterial chemoembolization and ablative technology. He is an assistant professor of diagnostic imaging and vascular interventional radiology at The Warren Alpert Medical School of Brown University.

Director, Interventional Radiology, The Miriam Hospital

Bryan Jay, MD, is the director of interventional radiology at The Miriam Hospital. He specializes in treating cancer and cancer-related problems using targeted minimally invasive image-guided procedures, including tumor ablation and catheter-directed vascular therapies. Dr. Jay is a clinical assistant professor of diagnostic imaging and interventional radiology at The Warren Alpert Medical School of Brown University.

Director, Division of Nuclear Medicine, Rhode Island Hospital

Richard B. Noto, MD, FACR, FACNM is the director of the division of nuclear medicine at Rhode Island Hospital and a professor (clinician educator) in the department of diagnostic imaging at The Warren Alpert Medical School of Brown University. He earned his medical degree from the University of Rochester School of Medicine. He completed his residency in diagnostic radiology at New York University Medical Center, and his fellowship in nuclear medicine at the Hospital of the University of Pennsylvania.

Dr. Noto’s research interests include nuclear medicine imaging in the evaluation of dementia and nuclear medicine therapy. He is a member of the Radiological Society of North America, the American College of Nuclear Medicine and the Rhode Island Radiological Society.

Interventional Radiologist

Ethan Prince, MD is a radiologist whose primary interest is vascular and interventional radiology. He is a Clinical Instructor of Diagnostic Imaging at The Warren Alpert Medical School of Brown University.

Radiologist

Robert C. Ward, MD is a radiologist at Rhode Island Hospital and an assistant professor of diagnostic imaging at The Warren Alpert Medical School of Brown University. Dr. Ward earned his medical degree from George Washington University School of Medicine and Health Sciences. He completed an internal medicine internship, diagnostic radiology residency, and women's imaging fellowship at Rhode Island Hospital, where he also served as chief resident.

Dr. Ward specializes in breast imaging and intervention, including breast cryoablation. He is president of the Rhode Island Radiological Society.

Director, Nuclear Medicine, The Miriam Hospital

Don C. Yoo, MD is the director of nuclear medicine at The Miriam Hospital and a professor of diagnostic imaging at The Warren Alpert Medical School of Brown University. He graduated from the State University of New York Science Center at Brooklyn. He completed his residency at Rhode Island Hospital and The Warren Alpert Medical School of Brown University and his fellowship at the Joint Program in Nuclear Medicine at several hospitals in Boston. Dr. Yoo has specialized training in nuclear medicine and positron emission tomography (PET). His main area of interest is in oncologic applications of PET.  

Dr. Yoo is heavily involved in teaching radiology residents and medical students at The Alpert Medical School, serving as the director of medical student radiology education and the co-director of the general radiology elective. Dr. Yoo has presented on nuclear medicine and PET/CT at many national meetings and been a grand rounds speaker at several academic institutions. Dr. Yoo is also involved with several national organizations, including the American College of Radiology (ACR), where he is the chair of the ACR Commission on Nuclear Medicine and Molecular Imaging.  

Medical Oncology

Oncologist

Khaldoun Almhanna, MD, MPH, is a gastrointestinal oncologist at the Lifespan Cancer Institute, specializing in hematology and oncology. Dr. Almhanna earned his medical degree from Damascus University in Syria and a master of public health degree from Case Western Reserve University in Cleveland. His research interests include esophageal cancer and gastrointestinal malignancies. He is a member of the American Medical Association, the American Diabetes Association and the American Society of Clinical Oncology. He is fluent in English, Arabic and French.

Director of Thoracic Oncology

Christopher Gerard Azzoli, MD, has joined the Lifespan Cancer Institute as director of thoracic oncology.  A native Rhode Islander, Dr. Azzoli received his medical degree from Johns Hopkins University School of Medicine in Baltimore, followed by residency training at Johns Hopkins Hospital. He completed his fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York then served there as faculty from 2002 - 2012.  He served as faculty at Massachusetts General Hospital Cancer Center in Boston from 2012 - 2018.

Dr. Azzoli is a former Chairman of the American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Committee, and was recently named a Fellow of ASCO.  He specializes in the care of patients with lung cancer, thymoma, and mesothelioma.

Director of Women's Cancers, Lifespan Cancer Institute, Clinical Director, Gynecologic Medical Oncology and Director of Medical Oncology, Rhode Island Hospital

Don S. Dizon, MD, FACP, FASCO, is an oncologist who specializes in women's cancers. He is the director of women's cancers at Lifespan Cancer Institute and director of medical oncology at Rhode Island Hospital. He is also a professor of medicine at The Warren Alpert Medical School of Brown University. His research interests are in novel treatments of women’s cancers and issues related to survivorship, particularly as they relate to sexual health after cancer for both men and women.

He is a prolific researcher and writer, and he has authored hundreds of publications, including peer-reviewed articles, books and book chapters. He is an active member of the American Society of Clinical Oncology, SWOG cancer research network, and the National Consortium of Breast Cancers, of which he has served as both vice president and president. 

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Hematologist/Oncologist

Rimini A. Breakstone, MD is a medical oncologist who specializes in gastrointestinal cancers. She received her medical degree from the Robert Wood Johnson Medical School at Rutgers University and completed her residency and fellowship at The Warren Alpert Medical School of Brown University. Dr. Breakstone is board certified in hematology, oncology and internal medicine.

Prior to joining the Lifespan Cancer Institute, she was an instructor at the Hospital of the University of Pennsylvania and served on the Unit Based Clinical Leadership Committee focused on inpatient quality improvement measures. Dr. Breakstone is a member of the American Society of Clinical Oncology and the American Medical Association. Her research interests include malignancies of esophagus, stomach, biliary system, pancreas, colon and rectum.

Hematologist Oncologist

James N. Butera, MD, is a board-certified hematologist/oncologist who treats patients with blood disorders including bleeding and clotting problems, leukemia, lymphoma, and multiple myeloma. He sees patients at the Lifespan Cancer Institute at Rhode Island Hospital and the Lifespan Ambulatory Care Center in East Greenwich. He is a clinical associate professor of medicine at The Warren Alpert Medical School of Brown University.

Dr. Butera’s research findings have been published in numerous peer-reviewed journals, and he is the site principal investigator at Lifespan for several chemotherapy studies. Among other honors, Dr. Butera has received the Brown University Dean’s Excellence in Teaching Award multiple times and been named one of Rhode Island Monthly magazine’s Top Docs for several years.

Director of Clinical Research, Director of Cancer Drug Development, and Associate Director of Division of Hematology/Oncology

Benedito A Carneiro, MD, is a medical oncologist with research interests in developmental therapeutics, solid organ malignancies and genitourinary cancers. As director of Cancer Drug Development for the Lifespan Cancer Institute of Rhode Island Hospital, The Miriam Hospital and Newport Hospital, and associate director of the Division of Hematology/Oncology, Dr. Carneiro leads clinical trials with novel treatments for cancers of the kidney, bladder, prostate, lung, pancreas, colon and other solid tumors.  His research explores innovative immunotherapy and genomic-driven treatment strategies.

His work has been published in several peer-reviewed articles and book chapters. He is a member of many professional societies and scientific committees, including the American Society of Clinical Oncology, American Association of Cancer Research. Dr. Carneiro speaks English and Portuguese. 

Hematologist/Oncologist

Pamela C. Egan, MD, is a hematologist at Rhode Island Hospital. Her interests include the treatment of acute leukemia, palliative care in hematologic malignancies, and physician advocacy education. She earned her medical degree from SUNY Upstate School of Medicine in Syracuse, New York, and completed her residency and fellowship at Rhode Island Hospital and The Warren Alpert Medical School of Brown University. Dr. Egan is a member of the American Society of Hematology and The American College of Physicians.

Clinical Director, Breast Medical Oncology at Rhode Island Hospital

Mary Ann Fenton, MD, FACP is an oncologist at the Lifespan Cancer Institute and a clinical associate professor at The Warren Alpert Medical School of Brown University. Her specialty area is the prevention and treatment of breast cancer.

Medical Oncologist

Hina Khan, MD, is a medical oncologist who specializes in thoracic cancers, and an assistant professor at The Warren Alpert Medical School of Brown University. She practices at Rhode Island, The Miriam and Newport hospitals, and is board certified in internal medicine, hematology and oncology. 

Dr. Khan's work has been published in several peer-reviewed medical journals and books. She is a member of the American Society of Hematology and the American Society of Clinical Oncology.

Oncologist

Randall Ingham, MD, is a hematologist/oncologist with the Lifespan Cancer Institute and is board certified in hematology oncology and internal medicine. Dr. Ingham is an assistant professor of medicine at The Warren Alpert Medical School of Brown University. He has been a research associate for the vaccine development group at ID Biomedical Corporation/GlaxoSmithKline biologics in Massachusetts. Dr. Ingham is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Director, Lifespan Cancer Institute Thoracic Multidisciplinary Clinic

Humera Khurshid, MD, is the director of the Lifespan Cancer Institute’s Thoracic Multidisciplinary Clinic, where she sees patients and collaborates with a team of specialists to coordinate patient care for newly diagnosed lung cancer patients. She is a medical oncologist with a special interest in geriatric oncology and the care of older lung cancer patients. She is also an assistant professor at The Warren Alpert Medical School of Brown University.

Oncologist

Mary L. Lopresti, DO, is an oncologist who specializes in breast and gynecological cancers at Rhode Island Hospital and Lifespan Cancer Institute. She serves as assistant professor of hematology oncology at The Warren Alpert Medical School of Brown University, and is also an assistant program director of the Brown University hematology oncology fellowship program.

Dr. Lopresti is currently involved in breast cancer research studies at Brown University and Rhode Island and The Miriam hospitals. Her  work has been published in several peer-reviewed journals, books and book chapters. She is a member of the American Society of Hematology and the American Society of Clinical Oncology.

Hematologist/Oncologist

Thomas A. Ollila, MD, is an hematologist/oncologist at Lifespan Cancer Institute. He earned his medical degree from Drexel University College of Medicine, and completed his residency in internal medicine and fellowship in hematology/oncology at Rhode Island Hospital. Dr. Ollila´s research interests include translational and clinical outcomes in lymphoma as well as addressing opioid use in cancer patients and survivors. In 2018, he was given the Conquer Cancer Foundation Merit Award by the American Society of Clinical Oncology. He is a member of the Alpha Omega Alpha Medical Honors Society, the American Society of Hematology and the American Society of Clinical Oncology.

Hematologist/Oncologist

Adam Olszewski, MD is a board-certified clinical hematologist/oncologist and researcher with the Lifespan Cancer Institute at Rhode Island Hospital. Dr. Olszewski is also an assistant professor of clinical medicine at The Warren Alpert Medical School of Brown University. He previously served as a cancer committee chair member and clinical oncologist/hematologist at the Cancer Center at Memorial Hospital of Rhode Island. Dr. Olszewski was also a physician director of outpatient infusion services at Kent County Hospital. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Hematologist Oncologist
Adult Hematologist Oncologist
Hematologist/Oncologist

Alexander G. Raufi, MD, is a hematologist/oncologist at the Lifespan Cancer Institute at Rhode Island and The Miriam hospitals, where he specializes in gastrointestinal oncology. Dr. Raufi received his medical degree from The Warren Alpert Medical School of Brown University and completed his residency in internal medicine at the University of California Irvine. He performed his fellowship in hematology/oncology at Columbia University/New York-Presbyterian. His research interests include the development of novel immunotherapy combinations in gastrointestinal malignancies. Dr. Raufi is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research.

Hematologist/Oncologist
Clinical Director, Women’s Medical Oncology at The Miriam Hospital
Medical Oncologist and Palliative Care Specialist

Angela Taber, MD, is a palliative care specialist and medical oncologist at the Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals. She has a special interest in issues involving patient quality of life, improving doctor-patient communication, and palliative care for patients with lung cancer. She is board certified in palliative care, and is an active participant in the Brown University Oncology Group, where she is involved in the development of clinical research protocols.

Taber earned her medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts, and completed her residency and hematology-oncology fellowship at The Warren Alpert Medical School of Brown University in Providence, Rhode Island. She is a member of the American Society of Clinical Oncology and the American Academy of Hospice and Palliative Medicine, and has been honored nationally for outstanding compassion and cancer care by the American Cancer Society. She is also the American Cancer Society’s designee to the Palliative Care and Quality of Life Interdisciplinary Advisory Council for the state of Rhode Island.

Hematologist/Oncologist

Sabrina M. Witherby, MD, is a hematologist/oncologist at Lifespan Cancer Institute. She is an assistant professor of medicine at The Warren Alpert Medical School of Brown University. She specializes in breast cancer and hematology and has particular interest in geriatric oncology, supportive care in oncology and medical education.

Dr. Witherby was named one of Rhode Island Monthly’s Top Docs in 2017 and awarded the Beckwith Family Teaching Award from The Warren Alpert Medical School of Brown University in 2013. She is a member of the American Society of Clinical Oncology, the Massachusetts Medical Society, and the Association of Program Directors in Internal Medicine. 

Palliative Care

Palliative Care Physician

Dana Levy Guyer, MD, is a palliative care physician at Lifespan Cancer Institute and Rhode Island Hospital. She received her medical degree from Vanderbilt University School of Medicine. She completed her residency training in internal medicine and pediatrics, as well as her fellowship in palliative care and hospice, at Vanderbilt University Medical Center. She is board certified in hospice and palliative medicine, internal medicine, and pediatric medicine, and is a member of the American Academy of Hospice and Palliative Medicine.

Palliative Care Physician

Edward Martin, MD is a board-certified specialist in hospice and palliative medicine. He is a professor of medicine (clinical), at The Warren Alpert Medical School of Brown University, as well as director of its Hospice and Palliative Medicine Fellowship Program and section chief of palliative medicine.

Dr. Martin earned his medical degree at The Warren Alpert Medical School of Brown University, followed by a residency at University of Rochester Associated Hospitals, Strong Memorial Hospital, in Rochester, New York. He received a master of public health degree from the Brown University School of Public Health.

Dr. Martin is certified in hospice and palliative medicine as well as internal medicine, geriatrics, and addiction medicine. He is chief medical officer of Hope Hospice and Palliative Care Rhode Island.

Dr. Martin is a member of the American Academy of Hospice and Palliative Medicine and the American Society of Addiction Medicine, among other professional societies. The Alpert Medical School has recognized Dr. Martin with several teaching awards; in 2015, he received the Josefina B. Magno Distinguished Hospice Physician Award from the American Academy of Hospice and Palliative Medicine. His research focuses on end-of-life care and decision-making.

Palliative Care Physician
Medical Oncologist and Palliative Care Specialist

Angela Taber, MD, is a palliative care specialist and medical oncologist at the Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals. She has a special interest in issues involving patient quality of life, improving doctor-patient communication, and palliative care for patients with lung cancer. She is board certified in palliative care, and is an active participant in the Brown University Oncology Group, where she is involved in the development of clinical research protocols.

Taber earned her medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts, and completed her residency and hematology-oncology fellowship at The Warren Alpert Medical School of Brown University in Providence, Rhode Island. She is a member of the American Society of Clinical Oncology and the American Academy of Hospice and Palliative Medicine, and has been honored nationally for outstanding compassion and cancer care by the American Cancer Society. She is also the American Cancer Society’s designee to the Palliative Care and Quality of Life Interdisciplinary Advisory Council for the state of Rhode Island.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Director of Stereotactic Radiosurgery

Jaroslaw T. Hepel, MD, serves as director of stereotactic radiosurgery at Rhode Island Hospital and as an assistant professor at The Warren Alpert Medical School of Brown University. He also serves as associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. He is board certified in radiation oncology by the American Board of Radiology. Hepel received his undergraduate degree at Cornell University and earned his medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA. 

Hepel has broad experience and knowledge, and is active in caring for patients with a wide range of malignant diseases. However, he holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the lung, brain, spine, liver and other sites. He is not only very active in the clinic but also has a keen academic interest in these areas. He has published several book chapters and multiple scientific papers, and has regularly presented his work at national meetings. Through his academic work, he strives to improve treatment outcomes for patients not only in regard to achieving higher cure rates but also to minimizing treatment side effects.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Radiation Oncologist

Paul P. Koffer, MD, is a radiation oncologist at Lifespan Cancer Institute at Rhode Island Hospital. Dr. Koffer received his undergraduate degree in biophysics from the University of Pennsylvania. He earned his medical degree from Temple University School of Medicine in Philadelphia and completed his residency in radiation oncology at Tufts Medical Center, where he was appointed chief resident. Dr. Koffer’s research and academic interests include the stereotactic radiosurgery and assessment and management of cancer pain.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, her master of science from Villanova University in Villanova, Pennsylvania, and her medical degree from Albany Medical College in Albany, New York. She completed an internship in internal medicine at Albany Medical Center, followed by a residency in radiation oncology at Tufts Medical Center in Boston. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board-certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, Massachusetts, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity-modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Oncologist-in-Chief, Radiation Oncology

David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Radiation Oncologist

Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.

Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.

Sarcoma

Medical Oncology

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Director of Women's Cancers, Lifespan Cancer Institute, Clinical Director, Gynecologic Medical Oncology and Director of Medical Oncology, Rhode Island Hospital

Don S. Dizon, MD, FACP, FASCO, is an oncologist who specializes in women's cancers. He is the director of women's cancers at Lifespan Cancer Institute and director of medical oncology at Rhode Island Hospital. He is also a professor of medicine at The Warren Alpert Medical School of Brown University. His research interests are in novel treatments of women’s cancers and issues related to survivorship, particularly as they relate to sexual health after cancer for both men and women.

He is a prolific researcher and writer, and he has authored hundreds of publications, including peer-reviewed articles, books and book chapters. He is an active member of the American Society of Clinical Oncology, SWOG cancer research network, and the National Consortium of Breast Cancers, of which he has served as both vice president and president. 

Pediatric Oncology

Pediatric Hematology/Oncology Specialist

Roma Bhuta, DO, is a pediatrician who specializes in hematology/oncology at Hasbro Children’s Hospital. She is an assistant professor at The Warren Alpert Medical School of Brown University. Dr. Bhuta is a member of the Children’s Oncology Group, the American Society of Pediatric Hematology/Oncology, the Consortium for New England Childhood Cancer Survivors and the Dana Farber Acute Lymphoblastic Leukemia Consortium.

Pediatric Hematology/Oncology Specialist

Bradley DeNardo, MD, is a board-certified pediatrician who specializes in pediatric hematology and oncology at Hasbro Children’s Hospital. He is an assistant professor of pediatrics at The Warren Alpert Medical School of Brown University. After attending The Warren Alpert Medical School, Dr. DeNardo continued dedicating his time to the medical students there by instructing them in pediatrics for the following nine years. In addition, Dr. DeNardo is a consulting physician at Women and Infants Hospital.

Dr. DeNardo’s work has been published in several peer-reviewed journals and books, and he has also presented his research at the local, regional and international levels. He is a member of a number of professional societies, including Children’s Oncology Group and the American Society of Pediatric Hematology/Oncology.

Chief of Pediatric Hematology/Oncology

Rishi R. Lulla, MD, MS, is the chief of pediatric hematology/oncology at Hasbro Children’s Hospital and an international expert in the care of children and young adults with brain and spinal cord tumors. After completing his residency and fellowship at Northwestern University in Chicago, Dr. Lulla spent several years as an attending physician on the pediatric neuro-oncology team at Northwestern. He has recently been given the Hero Award for outstanding dedication to pediatric neuro-oncology by the Pediatric Brain Tumor Foundation, and was named one of Chicago’s Top Cancer Doctors by Chicago magazine.

Dr. Lulla’s scientific work has been published in more than 20 peer-reviewed journals and two books. He has presented his findings on pediatric central nervous system tumors at the local, national, and international levels, and he has served as principal investigator to multiple grant-sponsored research investigations. His current research activities are focused on translating laboratory findings into novel treatment for children with brain and spinal cord tumors. He served as the executive chair of the Children’s Brain Tumor Tissue Consortium and is an active member of the American Society of Pediatric Hematology Oncology, the Children’s Oncology Group, and the Society of Neuro-Oncology.

Surgical Oncology

Chief of Surgical Oncology, Rhode Island Hospital

Thomas Miner, MD, is chief of surgical oncology at Rhode Island Hospital. He is an associate professor of surgery at The Warren Alpert Medical School of Brown University and an expert in gastric cancer surgery.

Dr. Miner's research interests include the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers with diffuse involvement of the abdominal cavity.

Chief of Musculoskeletal Oncology, Rhode Island Hospital

Richard Terek, MD is an orthopedic surgeon and musculoskeletal oncologist who specializes in reconstructive surgery and musculoskeletal oncology for adult and pediatric patients. He is an expert in the treatment of patients with bone and soft tissue tumors. He is actively engaged in medical education and is an NIH-funded investigator whose research is focused on understanding how bone cancer grows and spreads to other parts of the body, with the ultimate goal of developing new targeted therapies. He is professor in the department of orthopedic surgery at The Warren Alpert Medical School of Brown University.

Dr. Terek received his medical degree from the University of Chicago Pritzker School of Medicine in Chicago. He completed his orthopedic surgery residency at Loyola University Medical Center in Maywood, Illinois, and was an American Cancer Society Clinical Oncology Fellow in surgical oncology at Memorial Sloan-Kettering Cancer Center in New York, New York.

Dr. Terek is certified by the American Board of Orthopedic Surgery and is a fellow of the American Academy of Orthopedic Surgeons and the American College of Surgeons. He is past president of the Rhode Island Orthopedic Society and president-elect of the Musculoskeletal Tumor Society.

Learn more about the Orthopedics Institute »

Pediatric Surgery

Pediatric Surgeon

Arlet G. Kurkchubasche, MD, is a board-certified general and pediatric surgeon who has provided care at Hasbro Children's Hospital for the past 20 years. She is currently the program director for the Pediatric Surgery Fellowship Program at The Warren Alpert Medical School of Brown University, one of 40 such programs in North America.

In addition to her clinical training, she spent time in the labs at Children's Hospital of Pittsburgh, where she also developed her passion for management of patients with complicated health issues and intestinal failure, and this remains her clinical focus to date. She currently remains active in multiple clinical trials, especially those examining the outcomes of infants after surgical interventions. She has also spearheaded a pediatric program in thyroid cancer that provides more age-appropriate care to this population of children. Her focus on pediatric tumors has been evidenced by her position as the regional surgical co-principal investigator for the Children's Oncology Group and as the chair of the pediatric tumor board.

She remains active in all aspects of pediatric surgery (abdominal and thoracic, open and minimally invasive), airway endoscopy, and neonatal patent ductus arteriosus (PDA) ligations.

Pediatric Surgeon-in-Chief and Division Chief of Pediatric Surgery, Hasbro Children's Hospital

Francois Luks, MD, PhD, is pediatric surgeon-in-chief and division chief of pediatric surgery at Hasbro Children’s Hospital. 

Dr. Luks earned his bachelor’s degree from Rijksuniversitair Centrum Antwerpen, his medical degree from Universitaire Instelling Antwerpen, and his PhD in medical sciences from Catholic University Leuven, all in his native Belgium. He completed his residency in general surgery at Catholic Medical Center of Brooklyn and Queens (NY), then a residency in pediatric surgery at Hospital Ste-Justine in Montreal. He spent two years on a research fellowship through Catholic University of Leuven before joining both Hasbro and Women & Infants as Attending Surgeon in 1994. 

Dr. Luks has taken on progressively senior management roles at Hasbro, serving as director for trauma in the PICU for 15 years from 1995 to 2010, then subsequently director of trauma for the whole of Hasbro Children’s Hospital. He has served on and led more than a dozen standing and ad hoc committees at the hospital, from those in his specialty like the Pediatric Trauma Patient Care Committee, which he chaired, to those addressing issues in the broader hospital community, such as the Rhode Island Hospital Strategic Planning Committee. He has also continued to serve concurrently as attending surgeon at Women & Infants, and for several years each as attending surgeon at Morton Hospital (Taunton, MA) and New England Medical Center (Boston, MA). He also operates at St. Anne's Hospital in Fall River, MA. 

His research interests include fetal development and fetal surgery, and in particular the etiology of twin-to-twin transfusion syndrome. He was the site principal investigator for the first randomized study on endoscopic fetal surgery for this syndrome; the Brown Fetal Treatment Program was the only North American center participating in the study. The program is a founding member of the North American Fetal Treatment Network (NAFTNet); Dr. Luks has been a member of its Executive Committee since 2007.

Dr. Luks has published and presented widely, with more than 120 peer-reviewed publications and book chapters and more than 100 abstracts. He has served The Warren Alpert Medical School of Brown University for his entire 25 years in Providence, currently as director of the Program in Fetal Medicine, and professor of surgery, pediatrics and obstetrics & gynecology. Throughout the course of his time at Brown he has served as independent course director, faculty sponsor and thesis director to numerous promising medical students.

Pediatric Trauma Medical Director, Adolescent Bariatric Surgeon

Elizabeth J. Renaud, MD, is a surgeon at Rhode Island and The Miriam hospitals. She specializes in pediatric surgery and performs procedures at Hasbro Children’s Hospital. At Albany Medical Center, she was a pediatric trauma program director, associate professor of surgery and associate surgical residency program director. She held similar leadership positions at the University of Massachusetts Memorial Medical Center between 2009 and 2011. She was honored with the New York Rising Stars award in 2013.

Dr. Renaud’s research interests include trauma, outcomes research, minimally invasive surgery, and adolescent bariatric surgery. Her work has been published in several peer-reviewed journals and book chapters, such as the Journal of Pediatric Surgery and the Journal of Trauma and Acute Care Surgery. She has presented her research on topics such as endometrial cancer, appendicitis and childhood obesity. She is a member of the American Society for Metabolic and Bariatric Surgery, the Pediatric Trauma Society and the American Pediatric Surgical Association.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board-certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, Massachusetts, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity-modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Radiation Oncologist

Esther Yu, MD, is a radiation oncologist at Rhode Island Hospital. A 2012 graduate of Emory University School of Medicine, Dr. Yu has published her research on breast, central nervous system, and gastrointestinal cancers in many medical journals, and has presented at several national meetings for radiation oncology. She was named chief resident during her final year of residency at Tufts Medical Center in 2016-2017.

Dr. Yu is a winner of the American Brachytherapy Society’s 2016 HDR Scholarship Award. She holds a number of professional memberships including the American Society for Radiation Oncology and the American College of Radiation Oncology.

Skin Cancer/Melanoma 

Dermatology

Medical Oncology

Radiation Oncology

Chief of Brachytherapy Services

Yakub Puthawala, MD, is chief of brachytherapy services at Rhode Island Hospital and an associate clinical professor of radiation oncology at The Warren Alpert Medical School of Brown University. Puthawala is a board-certified radiation oncologist. He received his undergraduate degree in biology from Gujarat College and his medical degree from Municipal Medical College, both in Ahmedabad, India. He completed his fellowship training in radiation oncology at the University of Massachusetts Medical Center in Worcester, Massachusetts, and his residency training in radiation oncology at University Hospital in San Juan, Puerto Rico. His areas of clinical expertise include intraoperative radiation therapy, gynecologic and head and neck oncology, high dose rate (HDR) brachytherapy and intensity-modulated radiation therapy (IMRT). He is an adjunct associate clinical professor at Tufts University School of Medicine.

Oncologist-in-Chief, Radiation Oncology

David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Surgical Oncology

Chief of Surgical Oncology, Rhode Island Hospital

Thomas Miner, MD, is chief of surgical oncology at Rhode Island Hospital. He is an associate professor of surgery at The Warren Alpert Medical School of Brown University and an expert in gastric cancer surgery.

Dr. Miner's research interests include the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers with diffuse involvement of the abdominal cavity.

Surgical Oncology

Chief of Obstetrics and Gynecology, Rhode Island and The Miriam Hospitals

Christina A. Bandera, MD, is a gynecologic oncologist and director of the Center for Gynecologic Cancers at the Women’s Medicine Collaborative, and chief of obstetrics and gynecology at The Miriam Hospital and Rhode Island Hospital. Dr. Bandera received her undergraduate degree from Harvard University, and her medical degree from Johns Hopkins University School of Medicine. She completed her postgraduate training at Brigham and Women’s Hospital and Massachusetts General Hospital, and held fellowships at the University of Pennsylvania School of Medicine and the Mayo Clinic Hospital in Phoenix, Arizona.

Dr. Bandera is board certified in obstetrics and gynecology, and gynecologic oncology. She served as director of robotic surgery at Women & Infants Hospital, and is a member of the Society of Gynecologic Oncologists and the American Association for Gynecologic Laparoscopy.

Dr. Bandera’s clinical expertise includes the medical and surgical treatment of gynecologic cancers arising from the uterus, ovary, cervix, vagina and vulva, as well as the treatment of molar pregnancies and conditions resulting in abnormal pap smears. She has a special interest in cancer prevention and minimally invasive cancer surgery, including robotic surgery.

Surgeon

Rachel E. Beard, MD, is fellowship trained in surgical oncology and in surgery of the liver, pancreas, and biliary tract. She is an assistant professor of surgery at The Warren Alpert Medical School of Brown University. Her research focuses on minimally invasive approaches to liver and pancreas surgery, and immunotherapy for the treatment of widespread malignancies.

Surgeon-in-Chief, Surgery

William G. Cioffi, MD, FACS, is the surgeon-in-chief at the Miriam and Rhode Island hospitals. He is also the J. Murray Beardsley Professor and chairman of the department of surgery at The Warren Alpert Medical School of Brown University. Previously he was the chief of the burn study branch at the Institute of Surgical Research at Fort Sam Houston, Texas. He received his medical degree from the University of Vermont College of Medicine and completed his residency in general surgery at the Medical Center Hospital of Vermont.

He serves on various hospital, university and national committees dedicated to improving patient care for critically ill surgical patients. He is the past president of the American Association for the Surgery of Trauma, the International Surgical Group, the Surgical Critical Care Program Directors Society, the Society of University Surgeons and the North American Burn Society. Cioffi is currently the treasurer of the American College of Surgeons and the International Society of Burn Injuries and secretary of the American Burn Association. He is on the Executive Committee of the Board of Governors of the American College of Surgeons and serves on multiple other committees for the college and is a member of the The Halsted Society, American Surgical Association, Association for Academic Surgery, and Southern Surgical Association. Cioffi has also served on the editorial boards of such journals as Shock, Journal of Trauma, and Surgery and the American Journal of Surgery.

A board-certified general surgeon with added qualifications in surgical critical care, Cioffi’s clinical expertise and research interests are in the areas of pancreatic, oncologic, colorectal and trauma surgery. He has authored or co-authored more than 460 articles, book chapters and abstracts and continues to lecture nationally and internationally in his field.

Surgeon

Dr. Cotton is an endocrine surgeon who specializes in the surgical management of both benign and malignant diseases of the thyroid, parathyroid, adrenal, and endocrine pancreas. Originally from Texas, Dr. Cotton graduated Summa Cum Laude with a B.S. in Biomedical Science from Texas A&M University. He went on to receive his medical degree from the University of Texas at San Antonio School of Medicine with Alpha Omega Alpha honors. He then completed his internship and residency in general surgery at the University of North Carolina in Chapel Hill, NC. He subsequently became the Norman W. Thompson Fellow of Endocrine Surgery at the University of Michigan where he completed his endocrine surgery fellowship.

Dr. Cotton’s practice is primarily dedicated to taking care of patients with thyroid, parathyroid, and adrenal disease. He has expertise in thyroid ultrasound and ultrasound-guided thyroid FNA biopsies which are frequently performed in the office. He performs standard endocrine operations as well as minimally invasive parathyroidectomy and laparoscopic adrenalectomy.

Dr. Cotton’s research interests include parathyroid disease, papillary thyroid cancer, and thyroid ultrasound. He additionally participates in the education of both medical students and surgical residents at the Warren Alpert Medical School of Brown University.

Surgical Oncologist

Christine Emmick, MD is a board-certified general surgeon who cares for a wide array of surgical diseases. She received her medical degree from the Albany Medical College and completed her surgical residency at The Warren Alpert Medical School of Brown University and Rhode Island Hospital.

Dr. Emmick has a special interest in the treatment of both benign and malignant breast disease and is a member of the Lifespan Cancer Institute's multidisciplinary breast clinic team at The Miriam Hospital. She is an assistant clinical professor of surgery at The Warren Alpert Medical School of Brown University and a member of the American College of Surgeons.

More about the Lifespan Cancer Institute »

Gynecologic Oncologist

Tarra Evans, MD, is a gynecologic oncologist in the Center for Gynecologic Cancer at the Women’s Medicine Collaborative. She is a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. Dr. Evans is a member of the Society of Gynecologic Oncologists and has expertise in the surgical and medical treatment of precancers and cancers of the ovary, uterus, cervix, vagina and vulva, with a special interest in surgeries to alleviate cancer-related symptoms. She is fellowship trained in addressing complex cancer-related symptoms and completed the Harvard Interprofessional Palliative Care Fellowship at Massachusetts General Hospital and Dana-Farber Cancer Institute.

Director, Minimally Invasive Urology Institute; Director, Genitourinary Oncology at The Miriam Hospital

Dragan Golijanin, MD, is a director of the Minimally Invasive Urology Institute and director of Genitourinary Oncology at The Miriam Hospital. He also serves as an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Golijanin is board certified in urology. He is the 2019 recipient of the Alan Podis MD Teaching Award. 

Golijanin earned his medical degree at the University of Belgrade. He completed residencies at the University of Rochester School of Medicine, University Clinical Center in Belgrade and Hadassah Medical Center. He completed fellowships in urologic oncology at Memorial Sloan-Kettering Cancer Center, Cornell University and Hadassah Medical Center. He was the first to publish on near-infrared real-time imaging in open laparoscopic and robotic surgery.

Learn more about Dr. Golijanin’s research on www.Brown.edu »

Director, Breast Cancer Center of the Lifespan Cancer Institute
General Surgeon

Bradford Gray, MD, FACS, is a board-certified general surgeon affiliated with Newport Hospital. Dr. Gray received his medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania, and completed his resident training at Abington Memorial Hospital in Abington, Pennsylvania. He is a fellow of the American College of Surgeons. Dr. Gray has interest and expertise across a broad range of surgical services, including management of benign and malignant breast conditions; thyroid surgery; endoscopic procedures; management of malignant skin conditions, including melanoma; and advanced laparoscopic surgery, including hernia repair, colon surgery and foregut surgery.

Colorectal Surgeon

Adam Klipfel, MD, FACS, FASCRS, is a board-certified, fellowship-trained colorectal surgeon with expertise in colon cancer and surgical oncology. He received his medical degree from Mount Sinai School of Medicine in New York and completed a residency at New York Methodist Hospital. Dr. Klipfel gained further experience through a colorectal fellowship and an anorectal physiology fellowship at University of Southern California-affiliated hospitals. He has expertise in robotic surgery for benign and malignant disease. He is a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University and is program coordinator of the Colorectal Surgery Fellowship program. Dr. Klipfel is the current president of the Rhode Island Chapter of the American College of Surgeons. He is a fellow of the American College of Surgeons and the American Society of Rectal and Colon Surgeons as well as a member of Society for Surgery of the Alimentary Tract and the New England Society of Colon and Rectal Surgeons, among others.

Surgeon

Peter J. Mazzaglia, MD, is associate professor of surgery in the division of endocrine surgery at Rhode Island Hospital and the Warren Alpert School of Medicine at Brown University. Mazzaglia completed his residency in internal medicine at Dartmouth Hitchcock Medical Center and practiced internal medicine for three years in Portland, Maine prior to beginning his surgical training.

After his surgical residency at Maine Medical Center, Mazzaglia completed an additional year of endocrine surgery fellowship at the Cleveland Clinic in Ohio, where he specialized in surgery of the thyroid, parathyroid, adrenal and pancreas. As part of this fellowship, he gained expertise in the field of surgeon-performed ultrasound. He has been certified by the American College of Surgeons as an ultrasound instructor. Thyroid and parathyroid ultrasound, as well as ultrasound-guided thyroid FNA biopsy, is now an integral part of his practice. Unique to his fellowship training at the time was also specialized instruction in the performance of retroperitoneal laparoscopic adrenalectomy. When he came to Providence in 2006, he was the first surgeon in New England to routinely use this approach for adrenalectomy.

Research Highlights

  • The Changing Presentation of Hyperparathyroidism Over Three Decades. Mazzaglia P J, Berber E, Siperstein A E, Milas K M.  Archives of Surgery. 2008 Mar;143(3):260-6. 
     
  • Limited Value of adrenal biopsy in the evaluation of adrenal incidentaloma: A Decade of Experience.  Mazzaglia PJ, Monchik JM.  Archives of Surgery. 2009 May;144(5):465-70. 
     
  • Surgeon-performed ultrasound in patients referred for thyroid disease improves patient care by minimizing performance of unnecessary procedures, and optimizing surgical treatment. Mazzaglia PJ. WorldJournal of Surgery. 2010 Jun;34(6):1164-70. 
     
  • Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer. Yoo D, Ajmal S, Gowda S, Machan J, MonchikM, Mazzaglia PJ. World J Surg. 2012 Jun;36(6):1255-61. 
     
  • The Benign Thyroid Nodule: What is the appropriate follow-up strategy? Ajmal S, Rapoport S, Ramirez Battle H, Mazzaglia P. epubJournal of the American College of Surgeons. 2015 Jan. 

Thoracic Surgeon

Steven Milman, MD, is a board-certified general and thoracic surgeon and a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. He earned his medical degree from Cornell University Medical College, followed by a residency at Rhode Island Hospital. Dr. Milman completed a fellowship at Rush University Medical Center.

His clinical interests include endobronchial therapy and esophageal stenting for palliation of intrathoracic malignancies.

Chief of Surgical Oncology, Rhode Island Hospital

Thomas Miner, MD, is chief of surgical oncology at Rhode Island Hospital. He is an associate professor of surgery at The Warren Alpert Medical School of Brown University and an expert in gastric cancer surgery.

Dr. Miner's research interests include the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for cancers with diffuse involvement of the abdominal cavity.

Director, Division of Thoracic Surgery

Thomas Ng, MD, is a thoracic surgeon at Rhode Island Hospital and is an associate professor of surgery at The Warren Alpert Medical School of Brown University. Ng received his bachelor’s degree from the University of Toronto and his medical degree from Queen’s University School of Medicine in Kingston, Canada. He completed his residency in general surgery at The Warren Alpert Medical School of Brown University, a fellowship in critical care medicine at the University of Toronto and a fellowship in thoracic surgery at the University of Ottawa. Ng is active in a number of societies, including the American College of Surgeons, Canadian Association of Thoracic Surgeons, Cancer and Leukemia Group B, New England Surgical Society, Rhode Island Medical Society, Royal College of Surgeons of Canada, Society of Surgical Oncology and Society of Thoracic Surgeons.

Colorectal Surgeon and Co-Director, Program for Pelvic Floor Disorders, Women’s Medicine Collaborative

Leslie Roth, MD, FACS, FASCRS is co-director of the Program for Pelvic Floor Disorders in the Center for Women’s Gastrointestinal Medicine at the Women’s Medicine Collaborative and a colorectal surgeon at University Surgical Associates.

Dr. Roth is the Rosalyn and Joseph Sinclair Clinical Professor of Pelvic Floor Disorders and an assistant professor of surgery at The Warren Alpert Medical School of Brown University. She received her undergraduate degree from the University of Arizona and her medical degree from the Tel Aviv University Sackler School of Medicine, New York State/American Program, in Ramat Aviv, Israel and New York.

She completed her residency at Penn State Milton S. Hershey Medical Center. She is a graduate of the colon and rectal surgery fellowship at the University of Louisville in Kentucky. Dr. Roth is board certified in both general and colorectal surgery. She is also a fellow of both the American College of Surgeons and the American Society of Colon and Rectal Surgeons.

Dr. Roth's areas of clinical interest and expertise include colon and rectal cancer surgery, colonoscopy, laparoscopic/minimally invasive surgery, benign anorectal conditions, fecal incontinence and other pelvic floor disorders.

Interim Chief of Colorectal Surgery for Lifespan

Steven Schechter, MD, is the interim chief of colorectal surgery for Lifespan and a board-certified colorectal surgeon with special expertise in laparoscopic, minimally invasive surgery, fecal incontinence, pelvic floor reconstructive surgery, and colon cancer.

His research interests include rectal cancer treatment, and the link between anal cancer and human papilloma virus in women.

Dr. Schechter is a fellow of the American College of Surgeons, the American Society of Colon and Rectal Surgeons, and the New England Surgical Society of Colon and Rectal Surgeons, and a member of the International Society of Laparoscopic Colorectal Surgery.

Dr. Schechter is a member of Phi Beta Kappa and recipient of several awards for his teaching at The Warren Alpert Medical School of Brown University, where he is a clinical associate professor.

Associate Director, Breast Cancer Multidisciplinary Clinic at Newport Hospital

Julia Tassinari, MD, is a board-certified general surgeon and the associate director of the Lifespan Cancer Institute Breast Cancer Multidisciplinary Clinic at Newport Hospital.  Dr. Tassinari received her medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania, and completed her internship and residency at St. Elizabeth’s Medical Center in Boston, Massachusetts. Among her interests and expertise are minimally invasive surgery, including hernia repair, colon and foregut surgery; breast surgery; and skin and soft tissue surgery.

Surgical Oncologist

Charu Taneja, MD, is an affiliated surgical oncologist in the High-Risk Breast Program at the Women's Medicine Collaborative. She is a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. She received her medical degree from Maulana Azad Medical College, University of Delhi in New Delhi, India. Taneja completed a residency in surgery at the University of Medicine and Dentistry at New Jersey Medical School in Newark, New Jersey. She is a graduate of the surgical oncology fellowship at Boston University.

Taneja is board certified in surgery. She has published many original research articles in the field of oncology and breast surgery.

Chief of Musculoskeletal Oncology, Rhode Island Hospital

Richard Terek, MD is an orthopedic surgeon and musculoskeletal oncologist who specializes in reconstructive surgery and musculoskeletal oncology for adult and pediatric patients. He is an expert in the treatment of patients with bone and soft tissue tumors. He is actively engaged in medical education and is an NIH-funded investigator whose research is focused on understanding how bone cancer grows and spreads to other parts of the body, with the ultimate goal of developing new targeted therapies. He is professor in the department of orthopedic surgery at The Warren Alpert Medical School of Brown University.

Dr. Terek received his medical degree from the University of Chicago Pritzker School of Medicine in Chicago. He completed his orthopedic surgery residency at Loyola University Medical Center in Maywood, Illinois, and was an American Cancer Society Clinical Oncology Fellow in surgical oncology at Memorial Sloan-Kettering Cancer Center in New York, New York.

Dr. Terek is certified by the American Board of Orthopedic Surgery and is a fellow of the American Academy of Orthopedic Surgeons and the American College of Surgeons. He is past president of the Rhode Island Orthopedic Society and president-elect of the Musculoskeletal Tumor Society.

Learn more about the Orthopedics Institute »

Medical Director, Chair of Surgery

James Valente, MD, is a board-certified general surgeon affiliated with Newport Hospital. He received his medical degree from the Tufts University School of Medicine, and completed his residency at Morristown Memorial Hospital in Morristown, New Jersey. He spent 25 years caring for members of the U.S. military and their families, most recently as head of general surgery at Naval Health Care of New England. He has expertise across a broad range of general surgical services, including management of breast, thyroid and diseases of the intestinal tract; hernia repair; endoscopic procedures; management of skin and subcutaneous lesions; and advanced laparoscopic surgery, including gallbladder, colon surgery and surgery for acid reflux.

Director of General Surgery, The Miriam Hospital
Otolaryngologist-Head and Neck Surgeon

Richard Wein, MD is an otolaryngologist-head and neck surgeon at the Lifespan Cancer Institute. He earned his medical degree from Tufts University School of Medicine in Boston. He completed his otolaryngology-head and neck surgery residency at the University of Rochester Medical Center and subsequently completed his fellowship in head and neck surgical oncology at the University of Pennsylvania Health System.

Dr. Wein specializes in surgical management and reconstruction for patients requiring care for tumors of the head and neck.

Director, Cancer Survivorship Program

Doreen Wiggins, MD, MHL, FACOG, FACS, is an affiliated physician at the Women's Medicine Collaborative. She is director of the Cancer Survivorship Medicine program and is an assistant clinical professor at The Warren Alpert Medical School of Brown University.

She received her undergraduate degree from the University of Rhode Island and her medical degree from The Warren Alpert Medical School of Brown University. She pursued further medical training at Women & Infants Hospital and completed a Society for Surgical Oncology Breast Disease fellowship, and an intensive course in cancer risk assessment at the City of Hope in Los Angeles, California. Wiggins earned a master’s degree in healthcare leadership from The Warren Alpert Medical School of Brown University.

Wiggins is a fellow of both the American College of Obstetrics and Gynecology and the American College of Surgeons. She is the founder of Center for Obstetrics & Gynecology in Providence. Her areas of expertise are breast cancer surgery, gynecologic surgery, female cancer genetics, female sexuality and cancer survivorship.

Thoracic Cancer

Medical Oncology

Director of Thoracic Oncology

Christopher Gerard Azzoli, MD, has joined the Lifespan Cancer Institute as director of thoracic oncology.  A native Rhode Islander, Dr. Azzoli received his medical degree from Johns Hopkins University School of Medicine in Baltimore, followed by residency training at Johns Hopkins Hospital. He completed his fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York then served there as faculty from 2002 - 2012.  He served as faculty at Massachusetts General Hospital Cancer Center in Boston from 2012 - 2018.

Dr. Azzoli is a former Chairman of the American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Committee, and was recently named a Fellow of ASCO.  He specializes in the care of patients with lung cancer, thymoma, and mesothelioma.

Medical Oncologist

Ariel Birnbaum, MD, is a medical oncologist at Rhode Island Hospital. He received his medical degree from the Medical College of Ohio, completed his residency training at the University of Minnesota hospitals, and completed his fellowship in hematology/oncology at The Warren Alpert Medical School of Brown University. His clinical interests include combined modality treatment for lung cancer and end of life care. He is a member of the American Society of Clinical oncology and a participant in the Brown University Oncology Group.

Medical Oncologist

Hina Khan, MD, is a medical oncologist who specializes in thoracic cancers, and an assistant professor at The Warren Alpert Medical School of Brown University. She practices at Rhode Island, The Miriam and Newport hospitals, and is board certified in internal medicine, hematology and oncology. 

Dr. Khan's work has been published in several peer-reviewed medical journals and books. She is a member of the American Society of Hematology and the American Society of Clinical Oncology.

Director, Lifespan Cancer Institute Thoracic Multidisciplinary Clinic

Humera Khurshid, MD, is the director of the Lifespan Cancer Institute’s Thoracic Multidisciplinary Clinic, where she sees patients and collaborates with a team of specialists to coordinate patient care for newly diagnosed lung cancer patients. She is a medical oncologist with a special interest in geriatric oncology and the care of older lung cancer patients. She is also an assistant professor at The Warren Alpert Medical School of Brown University.

Medical Oncologist and Palliative Care Specialist

Angela Taber, MD, is a palliative care specialist and medical oncologist at the Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals. She has a special interest in issues involving patient quality of life, improving doctor-patient communication, and palliative care for patients with lung cancer. She is board certified in palliative care, and is an active participant in the Brown University Oncology Group, where she is involved in the development of clinical research protocols.

Taber earned her medical degree from the University of Massachusetts Medical School in Worcester, Massachusetts, and completed her residency and hematology-oncology fellowship at The Warren Alpert Medical School of Brown University in Providence, Rhode Island. She is a member of the American Society of Clinical Oncology and the American Academy of Hospice and Palliative Medicine, and has been honored nationally for outstanding compassion and cancer care by the American Cancer Society. She is also the American Cancer Society’s designee to the Palliative Care and Quality of Life Interdisciplinary Advisory Council for the state of Rhode Island.

Pulmonology

Pulmonologist

Douglas Martin, MD, specializes in pulmonary diseases and critical care medicine in the Interventional Pulmonary Program at Rhode Island Hospital. He graduated from The University of Rochester School of Medicine and Dentistry and then completed his residency and pulmonary and critical care fellowship at The Warren Alpert Medical School of Brown University. Martin has a special interest in lung cancer, bronchoscopy and interventional pulmonary procedures. He is board certified in internal medicine, pulmonary diseases, and critical care medicine. He is a member of The American Thoracic Society and The American College of Chest Physicians.

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Director of Stereotactic Radiosurgery

Jaroslaw T. Hepel, MD, serves as director of stereotactic radiosurgery at Rhode Island Hospital and as an assistant professor at The Warren Alpert Medical School of Brown University. He also serves as associate director of the Tufts-Affiliated Hospitals Residency Training Program in Radiation Oncology. He is board certified in radiation oncology by the American Board of Radiology. Hepel received his undergraduate degree at Cornell University and earned his medical degree at the University of Rochester. He completed internal medicine residency at the University of California Irvine Medical Center, and then went on to complete residency in the specialty of radiation oncology at Tufts Medical Center in Boston, MA. 

Hepel has broad experience and knowledge, and is active in caring for patients with a wide range of malignant diseases. However, he holds a particular interest and clinical expertise in the treatment of breast cancer and in stereotactic radiosurgery/radiotherapy for diseases involving the lung, brain, spine, liver and other sites. He is not only very active in the clinic but also has a keen academic interest in these areas. He has published several book chapters and multiple scientific papers, and has regularly presented his work at national meetings. Through his academic work, he strives to improve treatment outcomes for patients not only in regard to achieving higher cure rates but also to minimizing treatment side effects.

Radiation Oncologist

Paul P. Koffer, MD, is a radiation oncologist at Lifespan Cancer Institute at Rhode Island Hospital. Dr. Koffer received his undergraduate degree in biophysics from the University of Pennsylvania. He earned his medical degree from Temple University School of Medicine in Philadelphia and completed his residency in radiation oncology at Tufts Medical Center, where he was appointed chief resident. Dr. Koffer’s research and academic interests include the stereotactic radiosurgery and assessment and management of cancer pain.

Surgical Oncology

Thoracic Surgeon

Steven Milman, MD, is a board-certified general and thoracic surgeon and a clinical assistant professor of surgery at The Warren Alpert Medical School of Brown University. He earned his medical degree from Cornell University Medical College, followed by a residency at Rhode Island Hospital. Dr. Milman completed a fellowship at Rush University Medical Center.

His clinical interests include endobronchial therapy and esophageal stenting for palliation of intrathoracic malignancies.

Director, Division of Thoracic Surgery

Thomas Ng, MD, is a thoracic surgeon at Rhode Island Hospital and is an associate professor of surgery at The Warren Alpert Medical School of Brown University. Ng received his bachelor’s degree from the University of Toronto and his medical degree from Queen’s University School of Medicine in Kingston, Canada. He completed his residency in general surgery at The Warren Alpert Medical School of Brown University, a fellowship in critical care medicine at the University of Toronto and a fellowship in thoracic surgery at the University of Ottawa. Ng is active in a number of societies, including the American College of Surgeons, Canadian Association of Thoracic Surgeons, Cancer and Leukemia Group B, New England Surgical Society, Rhode Island Medical Society, Royal College of Surgeons of Canada, Society of Surgical Oncology and Society of Thoracic Surgeons.

Urology 

Medical Oncology

Director of Clinical Research, Director of Cancer Drug Development, and Associate Director of Division of Hematology/Oncology

Benedito A Carneiro, MD, is a medical oncologist with research interests in developmental therapeutics, solid organ malignancies and genitourinary cancers. As director of Cancer Drug Development for the Lifespan Cancer Institute of Rhode Island Hospital, The Miriam Hospital and Newport Hospital, and associate director of the Division of Hematology/Oncology, Dr. Carneiro leads clinical trials with novel treatments for cancers of the kidney, bladder, prostate, lung, pancreas, colon and other solid tumors.  His research explores innovative immunotherapy and genomic-driven treatment strategies.

His work has been published in several peer-reviewed articles and book chapters. He is a member of many professional societies and scientific committees, including the American Society of Clinical Oncology, American Association of Cancer Research. Dr. Carneiro speaks English and Portuguese. 

Hematologist Oncologist

Andre Luiz De Souza, MD, is a hematologist/oncologist at Lifespan Cancer Institute whose clinical interests include kidney, bladder, testicular and prostate cancers. Dr. De Souza is a member of the American Society of Clinical Oncology and the American Society of Hematology. He speaks Portuguese and Spanish. 
 

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Paul P. Koffer, MD, is a radiation oncologist at Lifespan Cancer Institute at Rhode Island Hospital. Dr. Koffer received his undergraduate degree in biophysics from the University of Pennsylvania. He earned his medical degree from Temple University School of Medicine in Philadelphia and completed his residency in radiation oncology at Tufts Medical Center, where he was appointed chief resident. Dr. Koffer’s research and academic interests include the stereotactic radiosurgery and assessment and management of cancer pain.

Surgical Oncology

Director, Minimally Invasive Urology Institute; Director, Genitourinary Oncology at The Miriam Hospital

Dragan Golijanin, MD, is a director of the Minimally Invasive Urology Institute and director of Genitourinary Oncology at The Miriam Hospital. He also serves as an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Golijanin is board certified in urology. He is the 2019 recipient of the Alan Podis MD Teaching Award. 

Golijanin earned his medical degree at the University of Belgrade. He completed residencies at the University of Rochester School of Medicine, University Clinical Center in Belgrade and Hadassah Medical Center. He completed fellowships in urologic oncology at Memorial Sloan-Kettering Cancer Center, Cornell University and Hadassah Medical Center. He was the first to publish on near-infrared real-time imaging in open laparoscopic and robotic surgery.

Learn more about Dr. Golijanin’s research on www.Brown.edu »

Director of Minimally Invasive Urologic Surgery

Gyan Pareek, MD, FACS is a director of the Minimally Invasive Urology Institute and director of the Kidney Stone Center at The Miriam Hospital. He is also a professor of surgery (urology) at The Warren Alpert Medical School of Brown University and Vice President of Operations at Brown Urology, Inc.  His areas of expertise include kidney stones, prostate cancer and benign prostatic hyperplasia. Dr. Pareek is board certified in urology. Dr. Pareek is the 2019 recipient of the Riesman Family Excellence in Teaching Award.

Pareek earned his medical degree from St. George’s University School of Medicine and completed his residency at Lenox Hill Hospital in New York. He also completed his laparoscopy and endourology fellowship at the University of Wisconsin. In 2006, Dr. Pareek was part of a team at The Miriam Hospital that performed the first robotic prostatectomy in southern New England.  He has held a number of leadership roles at the New England American Urological Association and the Rhode Island Urological Association.

Learn more about Dr. Pareek's research on www.Brown.edu »